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symmetric. dGTP almost always represents only 5-10% of the total dNTP pools in
cells. In anin vitroreplication system involving semiconservative replication from
an SV 40 origin, the mutation frequency of an Ml 3 phagemid replicatedby human
cell extracts in reaction mixtures containing "biologically biased" dNTP pools
estimated from HeLa cell nuclei is not significantly different from that seen when
replication is done with equimolar dNTP concentrations. Significant reduction of
dGTP pool while keeping other dNTPs at "biologically biased" dNTP concentrations
during replication reaction also did not increase mutation frequency. In contrast, in
vitroreplication with dNTP concentrations calculated from normal diploid fibroblast
cells, which are three- to four-fold lower in concentrations, showed a marked
reduction of the observed mutation frequency, showing the importance of overall
dNTP levels during replication on mutation frequencyin vitro.When whole-cell
dNTP concentrations in HeLa cells were measured during S-phase, dNTP levels
underwent a transient decrease in the middle of S-phase. Average HeLa cells' dNTP
levels were also found to correlate with average DNA accumulation rates during S-
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CHAPTER 1
INTRODUCTION
The careful balance between genomic stability and genetic variation in living
organisms is the basis of life's existence. Continued survival of organisms requires
faithful duplication of the genome. On the other hand, mutations, although some may
be detrimental, provide a source for genetic variations which are important in
evolutionary adaptation.
The spontaneous mutation rate in mammalian and most microbial cells is
estimated to be less than one mutation per billion base pairs per cell generation
(Kunkel, 1 992a). Contributing to this low mutation rate is the high fidelity of DNA
replication process and the variety of DNA repair mechanisms. DNA replication
multi-protein complexes, as first elements responsible for the low spontaneous
mutation rate, rapidly duplicate large amounts of genetic material with very high
accuracy. The DNA polymerase substitution error rate canbe as low as one in ten
million base pairs incorporated (reviewed in Kunkel, 1 992b). Several factors
contribute to the high fidelity of DNA polymerases. Replicative DNA polymerases
insert only about one incorrect nucleotide opposite a template for every tens of
thousands of correctly inserted bases. The exonucleolytic proofreading activity
associated with some DNA polymerases can cleave the incorrectly base-paired
template and inserted nucleotide during replication. In general, the proofreading
activity contributes about a hundred-fold further error reduction to achieve the low
substitution error rate (reviewed in Echols and Goodman, 1991).2
DNA repair proteins contribute significantly to the low spontaneous mutation
rate. DNA mismatch repair proteins correct mismatches that are present in newly
replicated DNA (reviewed in Modrich, 1991). Another repair protein, the uracil-
DNA glycosylase, which excises uracil from DNA, was reported to be present in the
replication foci (Otterlei et al., 1999), suggesting its role in repair of newly replicated
DNA. Still other repair proteins are available to correct the variety of premutagenic
lesions present in DNA to ensure accurate genome duplication.
As reviewed in Kunz and Kohalmi (1991), deoxyribonucleoside
triphosphates (dNTPs) as building blocks for DNA synthesis play a fundamental role
in DNA replication fidelity. The availability of balanced supplies of dNTPs during
replication has been shown to affect the DNA polymerase fidelityinvitro (reviewed
in Kunkel, I 992a). Perturbation of "normal" dNTP pool concentrationsin vivohas
been documented to produce a range of genetic effects associated with inaccurate
DNA repair and replication. However, dNTP pool measurements done in the
Mathews laboratory and elsewhere revealed that "normal" dNTP pools are
asymmetric in a variety of cells that have been studied (Mathews and ii, 1992). In
prokaryotes, the dNTP pool measured or "bulk" dNTP pools is not thought to be the
"replication-active" pool. The measured dNTP concentrations do not reflect the
effective dNTP concentrations seen by the DNA polymerase replication machinery.
In eukaryotic cells, it is still not completely understood whether there are
"replication-active" pools that are different from the measured dNTP pools
(reviewed in Mathews and Ji, 1992). In mammalian cells, which are the focus of this
thesis, deoxyguanosine triphosphate (dGTP) is almost always underrepresented
among all other dNTP pools measured. The existence of theasymmetric pools poses
questions regarding the possible contribution of the pools on the spontaneous
mutation rate. The relationship between dNTP levels and DNA replication fidelityin
vitro andin vivoin mammalian cells is the main focus of this thesis.
The following is a summary of processes involved in mammalian
chromosornal DNA replication as currently understood. Some aspects, such as thekinetic mechanism of DNA replication fidelity, have been taken from studies
involving prokaryotic DNA polymerases since the details of the kinetic mechanism
in mammalian DNA polymerases have not been elucidated.
BACKGROUND
DEOXYRIBONUCLEOSIDE TRJPHOSPHA TES
dNTP pooi measurement serves as quantitation of dNTP concentrations in
cells at the time of extraction. Each dNTP concentration measured is determined by
the rate of its production less the rate of its utilization in DNA replication and
turnover. DNA replication is almost exclusively the only utilization pathway for
dNTPs. However, at high concentration dATP has also been shown to participate in
the caspase-3 activation to induce apoptosis (Leoniet al., 1998,Oliveret al., 1996).
dNTP production in cells is achieved through two pathways:de nOVOsynthesis and
salvage pathway.
De NovoSynthesis of Deoxyribonucleotides
Synthesis of nucleotides from low-molecular-weight precursors such as CO2.
NH3, ribose phosphate and certain amino acids is termedde flOVOpathways
(Kornberg and Baker,1992,Mathewset al., 2000).Figure 1.1 illustrates the
overview of nucleotide metabolism taken from Mathews(1997).
The pathways forde novonucleotide synthesis are generally conserved in all
organisms studied. As there are two major classes of nucleotides, purines and
pyrimidines.de novosynthesis is also divided into two major categories, the purinenucleotide metabolism which produces adenine and guanine nucleotides, and the
pyrirnidine nucleotide metabolism which produces cytidine and thymine nucleotides
















































Figure 1.1. Overview of Nucleotide Synthesis. This schematic diagram is taken
from Mathews (1997). Upward and downward arrows represent allosteric activators
and inhibitors respectively.
The enzyme 5-phospho-u-c-ribosyl- 1 -pyrophosphate (PRPP)
arnidotransferase, which is feedback regulated by inosine5'-monophosphate (IMP),
adenosine5'-monophosphate (AMP), guanosine5'-monophosphate (GMP) and itssubstrate PRPP, is the initial commitmentto purine biosynthesis. PRPP synthase, the
enzyme controlling intracellular contents of PRPP, has also been reported to be
regulated by the end products ofde novopurine biosynthesis (Becker and Kim,
1987). Human PRPP synthase exists inat least two different isoforms (Roessleret
al., 1990). An associated PRPP synthase-associatedprotein of 39 kDa (PAP39)
affects the catalytic activity of theenzyme, and both PRPP synthase and PAP39 is
expressed differentially in different tissues, indicating different regulationof enzyme
in different tissues (Tatibanaetal., 1995).
A trifunctional enzyme involved in the next threesteps ofde novopurine
biosynthesis has been isolated from human cells (Pochet al.,1998). This
trifunctional enzyme encodes glycinamide ribonucleotide synthase,aminoimidazole
ribonucleotide synthase and glycinamide ribonucleotide transformylase(GAR
Tfase), and there is evidence that the expression of this multifunctionalprotein is
differentially regulated during tissue development (Brodskyet al.,1997). Another
multi-functional enzyme in purinede novobiosynthesis isolated from human cells is
5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP
cyclohydrolase (AICAR Tfase/IPCHase) (Raylet al.,1996, Yamauchiet al.,1995,
Szabadoset al.,1994). In addition to the multi-functionalenzymes, isolation of a
large complex of purine biosyntheticenzymes involving folate enzymes GAR Tfase,
AICAR Tfase, and also including serine transhydroxymethylase andenzymes for
synthesis of 1 0-formyl tetrahydrofolate and other folate cofactors fromchicken liver
has also been reported (Caperelliet al.,1980).
The second point of regulation of purine biosynthesis isat the brach point of
either ATP or GTP formation from IMP. Adenylate synthesis byadenylosuccinate
synthase requires GTP as cofactor, and it is up-regulated by GTP (Van derWeyden
and Kelly, 1974). On the other hand, the rate of inosinate conversionto GTP is
regulated by ATP level (Holmeset al.,1974).
The human genes encoding the first threeenzymes involved in pyrimidine
synthesis, carbatnoyl phosphate synthase,aspartate carbamoyl transferase, anddihydroorotase have been cloned (Iwahanaet al.,1996), and they are linked together
to form one complex polypeptide (termed CAD). Thetrifunctional enzyme is
regulated both at the transcriptional andpost-transcriptional levels (Rao and Church,
1988), and it has been shown that the firstenzyme in the complex polypeptide,
carbamoyl phosphate synthase, is aliosterically regulated(Tatibana and Shigesada,
1972, reviewed in Jones, 1980)as well as activated by cAMP-dependent protein
kinase A (PKA) phosphorylation (Carreyet al.,1985). CAD is also regulated by
mitogen-activated protein (MAP) kinase cascade (Graveset al.,2000). CAD level
has been shown to be correlated with cell growth,and its level is highest at the G 1-
phase of the cell cycle (Rao and Church, 1988,Morfordet al.,1994).
The second multifunctionalenzyme involved in pyrimidine biosynthesis is
UMP synthase, which is composed oforotate phosphoribosyl transferase and
orotidylate decarboxylase. The human UMP synthasebifunctional protein has been
cloned (Suttleet al..1988). Although it is thought that the multifunctionalenzymes
channelled the five intermediates of pyrimidinebiosynthesis, carbamoyl phosphate,
carbamoyl aspartate, dihydroorotate,orotate, and orotidylate, there is evidence to
suggest that channelling is not efficient in the UMP synthasebifunctional enzyme
(Traut, 1989). Each of the catalytic sites in the humanUMP synthase bifunctional
enzyme is more stable when covalently linked (Yablonskiet al.,1996), suggesting a
structural role for the existence of the multienzymecomplex.
The next step for UMP, AMP and GMP is the reversibleconversion of
nucleoside monophosphate to diphosphate, andhuman tissues contain a uridylate-
cytidylate kinase (UMP-CMPK). five isozyrnesof adenylate kinase (AK) and several
guanylate kinase (GUKs) (reviewed in VanRompayet al.,2000). These kinases are
mostly specific for each base but notvery specific to the sugar. Ribonucleoside
diphosphates are then reduced to deoxyribonucleosidediphosphates by
ribonucleotide reductase, a keyenzyme in nucleotide metabolism, and finally
deoxyribonucleoside diphosphatesare converted to triphosphates by nucleoside
diphosphate kinase, which catalyses reversiblephosphate exchanges betweennucleoside diphosphates and triphosphates(reviewed in Lascu, 2000). Six human
isoforms of nucleoside diphosphate kinase(NM23-H1 to NM23-H8) exist (Lacombe
et al.,2000), and NM23-H1 and NM23-H2 have been implicatedin metastasis (Stahl
et al.,1991) and pathogenesis (Hailatet al.,1991, Zhanget al.,1997) of tumors
(reviewed in Veronet al., 1994).
Ribonucleotide reductase (RNR) is the rate-limitingenzyme in nucleotide
biosynthesis for DNA replication (Reichard, 1993), and it isallostericaly regulated
so that its activity corresponds to the needs of dNTPs for DNA synthesis (Hendricks
and Mathews, 1998, Chimploy and Mathews, 2001). MammalianRNR is composed
of two nonidentical subunits: RI, which contains redox-active disulfidesactive site
and two different allosteric nucleoside triphosphate bindingsites (Thelander and
Reichard. 1979, reviewed in Jordan and Reichard, 1998), andR2, which has the
essential iron center-generated tyrosyl free radical (Thelanderet al.,1985). Binding
of ATP to one of the allosteric sites, the activity site, activatesthe enzyme, while
binding of dATP to the same site inhibits all four activities. Bindingof ATP, dATP,
dTTP or dGTP to the other allosteric site, the substrate specificitysite, governs the
activity of the enzyme for specific substrates (Thelander and Reichard,1979). ATP
stimulates the reduction of UDP and CDP, dTTP stimulates reductionof GDP, and
dGTP stimulates ADP reduction. RNR activity in cells is regulatedthroughout the
cell cycle (Engstromet al.,1985). The enzyme activity increases as the cell proceeds
through S-phase. Transcription of both Ri and R2 is specificto S-phase (Bjorklund,
1990). However, the level of Ri protein, which hasa half-life of more than 20 hours,
has been shown to be constant throughout the cell cycle (Engstromet al.,1985,
Mannet al.,1988). R2 protein, with a short half-life of 3 hours, has been shownto
be specifically stabilized in S-phase and degraded in late mitosis (Chabesand
Thelander, 2000), and since R2 is limiting for activity, it confers the cell cycle
regulated activity of RNR (Erikssonet al.,1984). Although increased RNR activity
is observed in S-phase, it has been shown that overproductionof R2 during Sphase
does not result in an increase in dNTP pools (Akerblomet al.,1981), stressing theimportance of allosteric control of RNR (Weinberg et al., 1981) together with dNTP
degradation pathways in keeping a tight control on the level of dNTP pools in cells
(reviewed in Reichard, 1988). Ri and R2 are undetectable in quiescent or terminally
differentiated cells (Mann et al., 1988). However, p53-inducible R2 has been shown
to be able to function with Ri, and UV irradiation of G0/G1 mouse fibroblast cells
results in expression of Rl protein, indicating the role of R1/p53R2 in damage-
induced nucleotide synthesis in resting cells (Guittet et al., 2001).
Synthesis of thymidylate is achieved through either the action of dCMP
deaminase or dUTPase resulting in dUMP (Fig. 1.1.). dCMP deaminase (Ellims et
al., 1 981, Ellims et al., 1983, Weiner ci al., 1993, Weiner et al., 1995) supplies most
of the dUMP in mammalian cells. This enzyme is allostericaly controlled; it is
activated by dCTP and inhibited by dTTP (Ellims el al., 1983). dUMP is then
converted to thymidylate by the enzyme thymidylate synthase (TS), which acts by
transferring a methylene group from methylene tetrahydrofolate (THF) to
deoxyuridylate accompanied by the reduction of the group to CH3 (reviewed in
Carreras and Santi, 1995, Montfort and Weischsel, 1997). Regeneration of THF is by
dihydrofolate reductase and this regeneration process is essential in sustaining
thymidylate synthesis. Translation of human TS mRNA is regulated by its own
protein product through binding of TS protein to at least two distinct sequences on its
own mRNA that results in translational repression (Chu ci al., 1991, Chu etal.,
1993). In addition, there is evidence to suggest that TS protein regulates the
expression of p53 through the same translational repression, overexpression of TS
protein decreases the translational efficiency of p53 mRNA, suggesting a role for TS
in cellular gene expression (Ju et aT, 1999).9
Salvage Pathway for Synthesis of Deoxyribonucleotides
Salvage pathways utilize broken down nucleotides from degraded DNAor
RNA in the form of nucleobases to form nucleotides. The salvage pathway is
physiologically important in resting cells, suchas most mammalian tissues, sincede
novosynthesis of nucleotides is lacking in these cells (reviewed in Amer and
Eriksson, 1995). The importance of the salvage pathway in cycling cells has also
been implicated. Cohenet al.(1983) have shown that in S-phase thymocytesde novo
synthesis is responsible for production of purine nucleotides, whereas salvage
pathway predominantly supplies the pyrimidine nucleotides for DNA synthesis. The
enzymes involved in catabolism of nucleotides and salvage pathway are also
important in regulating the levels of intracellular dNTP pools (Reichard, 1988).
There are several pathways for salvage of nucleotides. The first is direct
conversion of a nucleoside to a nucleotide through kinases. In human cells
deoxycytidine kinase (Bohman and Eriksson, 1988, Dattaet al., 1989a,b), thymidine
kinase 1 (Sherley and Kelly, 1988, Munch-Petersenet al.,1991), thymidine kinase 2
(Erikssonet aL,1991, Munch-Petersonetal.,1991, Janssonetal.,1992),
deoxyguanosine kinase (Yamada ci'al.,1982, Sarup and Fridland, 1987) and
adenosine kinase (Yamadaet al.,1981) are responsible for conversion of nucleosides
to nucleotides. Deoxycytidine kinase (dCK) phosphorylates dCyd, dAdo and dGuo
(Dattaetal.,1989b, Kim and Ives, 1989). While the cell cycle variation in dCK
activity is different in different cell lines, dCK mRNA levelwas mostly constant, and
therefore, dCK is thought to be constitutively expressed during the cell cycle in most
cell lines studied (lHlengstschlageret al.,1993). Thymidine kinase 1(TKI)
phosphorylates Thd and dUrd (Erikssonet al.,1991, Munch-Petersen ci'al.,1991).
TK 1 activity is closely correlated with S-phase (Brent, 1971, Pegoraro and
Bernengo, 1971, Taylor ci'al.,1972, Bello, 1974) with evidence that transcription
factor E2F regulates the S-phase dependent expression of TK1 (Ogris cial.,1993).
In addition, tight regulation mechanisms of TK1 throughout cell cycle byED]
transcriptional, translational and post-translationalregulatory mechanism have been
demonstrated (Stewart et al., 1987, Kauffmanand Kelly, 1991, Chang and Huang,
1993, Chang et al., 1994). Thymidine kinase2 (TK2) is a mitochondrial enzyme
encoded by a nuclear gene (Attardi and Schatz,1988, Hart! and Neupert, 1990). It
phosphorylates Thd, dCyd, and dUrd (Erikssonet al., 1991, Munch-Petersen et al.,
1991, Jansson et al., 1992). Thisenzyme is not cell-cycle-regulated (Kit, 1985).
Deoxyganosine kinase (dGK) isa mitochondrial enzyme (Gower et al., 1979), and it
phosphorylates dGuo and dAdo (Yamadaet al., 1982, Sarup and Fridland, 1987,
Wang et al., 1993). Human dGK has been shownto be homologous in sequence to
human dCK (Johansson and Karlsson, 1996).
The conversion of nucleoside monophosphateto nucleoside through the
action of 5' -nucleotidases, playsan important role in fine tuning the intracellular
deoxyribonucleotide pool levels (Chanet al., 1974, Reichard, 1988, Hoglund and
Reichard, 1990a,b). Three important classes of the5'-nucleotidase in higher
organisms include the cytosolic highKMnucleotidase (hkm-NT) (Itoh, 1981), the
cytosolic 5'(3')-deoxynucleotidase (dNT-1)(Fritzon and Smith, 1971) and the
mitochondrial enzyme (dNT-2) (Henkeet al., 1989, Rampazzo ci al., 2000).
Recently it was shown that 5' (3' )-deoxynucleotidase(dNT- 1), which preferably
dephosphorylates pyrimidine deoxyribonucleotides 5'-monophosphates (Hoglund
and Reichard, 1 990a), is involved in thesubstrate cycles regulating pyrimidine
nucleotide pools in human 293 and hamsterV79 cells (Gazziola et al., 2001). The
highKM5'-NT may function as phosphotransferase (Worku andNewby, 1982)
supplementing the functions of the deoxyribonucleosidekinases in the salvage
pathway (Amer and Eriksson, 1995).
Also important is the reversible conversion of baseto nucleosides through
phosphorylases. in humans, theenzymes in this class include purine nucleoside
phosphorylase (Stoeckler et al., 1978, Zaimiset al., 1978), uridine phosphorylase
(Watanabe and Uchida, 1995, Liuci al., 1998) and thymidine phosphorylase
(Kubilus et al., 1978, Desgrangeset al., 1981). Although the regulatory mechanismsof these enzymes are not as clear, the metabolic roles of theenzymes have been
studied extensively. Deficiency in purine nucleoside phosphorylase leadsto
impairment of T-cell function (reviewed in Bzowskaet al.,2000). It was shown that
purine nucleoside phosphorylase synthesis is upregulated significantly in the early
stages of T-cell transformation (Neoteet al.,1985). Mutations in the thymidine
phosphorylase gene has been shown to be responsible for mitochondrial
neurogastrointestinal encephalomyopathy (MNGIE) (Nishinoetal., 1999, Nishinoet
al.,2001). Increase in thymidine pool is thought to result in mitochondrial nucleotide
pools imbalance leading to the mitochondrial DNA alterations observed in MINGlE.
Other important salvage pathways include interconversion by base alteration
by deaminases, and direct conversion ofa base into a ribonucleotide through
phosphoribosyl transferases. An example of deaminases is human adenosine
deaminase, which presents in multiple molecular forms in human tissue (Van der
Weyden and Kelley, 1976). Defects in thisenzyme have been implicated in severe
immunodeficiency (reviewed in Hirschhorn, 1990). An example of the transferases is
hypoxanthine-guanine phosphori bosyl transferase (HGPRTase). Deficiency in
human HGPRTase has been implicated in Lesch-Nyhan syndrome (LNS),
characterized by excessive purine production andsevere neurological manifestation
(Wilson and Kelley, 1983, reviewed in Stout and Caskey, 1985).
DNA REPLICATION
The process of chromosomal DNA replication in mammalian cells is
compartmentalized within the nucleus. Therefore, DNA replication is partitioned
from the cytoplasm, which is the site of synthesis of proteins and other cofactors that
regulate and function in DNA synthesis (reviewed in Malkas, 1998). Another aspect
that adds to the complexity of mammalian DNA replication is that the mammalian
chromosome is a complex nucleoprotein structure composed of both DNA and12
protein (reviewed in Huberman, 1973). Mammalian chromosomes also contain
multiple replication origins per DNA molecule (1-luberman and Riggs, 1966). It can
be envisioned that the DNA replication process in mammalian cells is a highly
coordinated and complex process; however, it is not thoroughly understood.
Proteins Involved in Mammalian DNA Replication
DNA Polymerases
In eukaryotes, DNA polymerases a with the tightly associated primase
activity, ö andare the major replicative DNA polymerases (reviewed in Stiliman,
1994). However, pot c was found to be present only duringin vivoreplication and
not in the SV 40invitro replication system used to study mammalian DNA
replication. All of the replicative DNA polymerases have one large subunit that
contains the polymerase active site and, with the exception of poi a-primase, the
same subunit or an associated polypeptide carries a proofreading 3'5' exonuclease
(reviewed in Baker and Bell, 1998). This 3' -5' exonuclease activity contributes
about three orders of magnitude to the fidelity of DNA replication (Kunkel, 1988).
Sequence alignments, structural studies, and site-directed mutagenesis studies
indicate that the exonuclease and the polyrnerase active sites of these enzymes can be
considered largely independent catalytic modules (Joyce and Steitz, 1994). The
mechanism of exonucleolytic proofreading is best understood for E. coil DNA
polymerase I (poll) (Freemont el ai., 1988, Joyce and Steitz, 1994). In E. coil DNA
poll, the polymerase and exonuclease active site are separated by 30 A° but linked
by a shared binding cleft. A properly base-paired template would be preferred for
polymerization, while an unmatched terminus would result in fraying and switching
of the single-strand to the exonucleolytic site.The list of mammalian enzymes known to catalyze polymerisation of DNA
has grown remarkably longer in the last couple ofyears. Although mammalian
chromosomal replicative DNA polymerasesare still believed to be DNA
polymerases a, ö andE,new subsets of DNA polymerases are also thought to
participate in S-phase replication in the event of DNA damageor misalignment of
primer-template junction, therefore, ensuring the completion of S-phase. Some of the
polymerases are capable of traversing past lesions accurately while others with less
accuracy. It is still a question of how all of the different DNA polymerases can
access each of its specialized substrate, such as specific DNA lesions, during DNA
synthesis (reviewed in Sutton and Walker, 2001). Adding to the complexity,some of
the newly discovered polymerases do not yet have clearly understood functions.
Mammalian DNA Poly,nerases a, öand
DNA pot a is one of the major polymerases involved in mammalian DNA
synthesis (reviewed in Wang, 1991). The structure of the whole complex and of the
individual subunits in this DNA polymerase-primase complexseems to be conserved
in all eukaryotes studied. Human poia consists of four subunits: the subunit
associated with the polymerase activity, which is about 165 kDa (Wang etal., 1989),
a 70-kDa essential subunit of unknown function and the primase subunits of 58 kDa
and 48 kDa (Wang et al., 1984). The two small subunits, which constitute the
primase activity, are responsible for synthesizing small RNA primers of about 10
nucleotides in length. It is because of the tight association of the polymerization and
priming functions that pol a is more correctly referred to as DNA polymerase-
primase. The mouse prirnase gene is induced during transition from quiescence to
proliferation, and in actively proliferating cells the gene is constitutively expressed
throughout the cell cycle (Tseng et al., 1989). Human DNA polyrnerasea is
phosphoryiated in a cell-cycle-dependent maimer (Nasheuer et al., 1991); the14
catalytic polypeptide is found to be phosphorylated throughout the cell cycle and
hypophosphorylated in mitotic phase, whereas the 70-kDa subunit is phosphorylated
only in mitotic phase. Cell-cycle dependent phosphorylation of the 58- and 48-kDa
subunits were not observed. The cyclin-dependent phosphorylation of DNA pola is
suggested to affect the regulation of the initiation of DNA replication (S chub et al.,
2001).
Human DNA polis a heterodimeric protein complex composed of two
subunits of approximate molecular weight 125 and 50 kDa (Lee et al., 1991). The
larger 125-kDa subunit is associated with both the DNA polymerase activity and the
proofreading 3'-5' exonuclease activity (Lee et al., 1991, Simon et al., 1991).
Proliferating cell nuclear antigen (PCNA) is reported to interact with the N-terminal
region of the I 25-kDa subunit (Zhang et al., 1995). Polis a major replicative
polymerase and is required for DNA synthesis of both the leading and lagging
strands during SV 40 replication in vitro as confirmed in a UV-crosslinking study
(Zlotkin et al., 1996). Common characteristics that are used to identify mammalian
pol S are the proofreading 3' -5' exonuclease activity (Kunkel etal., 1987),
sensitivity of enzyme to the drug aphidicolin, low polymerase processivity in the
absence of PCNA (Tan ci al., 1986, Syvaoja et al., 1990), and resistance to the pol
a-specific drug N2-p-n-butylphenyl)-2 '-deoxyguanosine 5' triphosphate
(BuPhdGTP) (Lee et al., 1985) (reviewed in Burgers, 1989).
The human form of pol8consists of two subunits of approximate molecular
weight 250 and 55 kDa (Syvaoja and Linn, 1989, Lee and Toomey, 1987, Syvaoja ci
al., 1990). Its involvement in chromosomal DNA replication is suggested bya UV-
crosslinking study that found that pol8existed in replicating chromosornal DNA,
although pol8does not seem to be required for SV 40 DNA replication (Zlotkin et
al., 1996). Pol c does have proofreading exonuclease activity and is distinguished
from poi S because of its lack of stimulation by PCNA (Syvaoja et al., 1990, Lee ci15
al., 1991). The level of mRNA expression of polin cells is strongly correlated with
cell proliferation (Kesti et al., 1993).
Mammalian DNA Polymerase
DNA polymerase(polc)is one of the newly discovered polymerases, and it
is in the same class-B family of DNA polymerases as pola,and c (reviewed in
Burgers et al., 2001). Polis an error-prone DNA polymerase that is induced during
DNA damage, and recently it has been implicated to act together with poli (see
UmuC-DinB-Rad3 0-Rev] SuperfamilyofDNA Polymerases) to bypass DNA lesions
(Johnson et al.. 2000).
Mammalian DNA Polymerase /1
Human DNA polymerase 3 (pol 13) is a polypeptide with molecular weight of
39 kDa (Mullen and Wilson, 1997). Pol
1does not have a proofreading exonuclease
activity, and kinetic analysis has shown it to be a distributive enzyme. However,
short gaps with 5'-phosphate termini are filled processively (Singhal and Wilson,
1993). This enzyme is thought to function in short-patch repair, including base-
excision repair.
Mammalian DNA Polymerase 2 and p
Mammalian DNA polymerase X (pol X) andt(polt)belong in the X-class of DNA
polymerases together with pol 13 (reviewed in Burgers et al., 2001). Human pol A. has16
been shown to have 5'-deoxyribose-5-phosphate lyase (dRP lyase) activity,
suggesting its role in single-nucleotide base excision repair in mammalian cells
(Garcia-Diaz et al., 2001). Polthas been suggested to participate in somatic hyper-
mutation of immunoglobulin genes (Dominguez ci al., 2000, reviewed in Ruiz et al.,
2001).
Mammalian DNA PoIymerase a
Human has two genes for DNA polymerase a (pol a). Pol a is distantly
related to pol X superfamily of DNA polymerases, and it (TRF4) is required for
sister chromatid cohesion (Burgers et at., 2001, Sutton and Walker, 2001).
Mammalian DNA Polymerase y
Human DNA polymerase y (pol y) was purified from HeLa cells, and it
consists of two subunits of molecular weight 140 and 54 kDa (Gray and Wong,
1992). The catalytic polymerase activity resides in the larger 140-kDa subunit. Pol y
is located in mitochondria, and it is the mitochondrial replicative DNA polyrnerase
(Bolden et al., 1977, reviewed in Wang, 1991). This enzyme has a proofreading
3'-5' exonuclease activity (Gray and Wong, 1991, Kunkel and Soni, 1988, Kunkel
and Mosbaugh, 1989).
UmuC-DinB-Rad3 0-Rev] Superfamily of DNA Polymerases
The newly described UmuC-DinB-Rad3O-Revl superfamily of DNA
polymerases have been identified to exist in both prokaryotes and eukaryotes. Most17
of these polymerases are known to function in translesion synthesis to allow
damaged templates during replication to be bypassed and hence ensuring S-phase
progression (reviewed in Sutton and Walker, 2001). Human poi i encoded by
hRAD3OA/XP-V gene, and pol,encoded by the hRAD3OB gene, are members of
the RAD3O subfamily. Biochemical characteristic of human pol r indicates that it is
able to bypass cis-syn cyclobutane pyrimidine dimers accurately by inserting two
adenines opposite the lesion (Nelson et al., I 996a, Johnson etal.. 2001). Pol i. has
been shown to have a 5' -deoxyribose phosphate lyase activity implicating its role in
base excision repair (Bebenek et al., 2001). PolK,encoded by the hDINBI gene, is
another polymerase in this superfamily. Rev 1 p or deoxycytidyl transferase is a
related enzyme to the superfamily, and it functions in translesion synthesis (Nelson
ci al., 1 996b). PolKis suggested to have a role in spontal1eous mutagenesis due to its
low fidelity but moderate processivity (Ohashi et al., 2000).
Other Mammalian DNA Polymerases
Other mammalian DNA polymerases that are newly discovered include poi
0 which possibly functions in repair of DNA cross-links (reviewed in Sutton and
Walker, 2001).
Other Proteins in Mammalian Replication Forks
The replication fork contains several key proteins other than DNA
polymerases that synthesize new strands and the editing exoriuclease associated with
the replicative polymerase. These proteins include the accessory proteins that control
interaction of the polymerases with the DNA and the helicase that melts the double18
helix to generate a replication fork (Baker and Bell, 1998). Enzymes present in the
eukaryotic replication fork have been identified through in vitro replication studies
using mammalian cell extracts that support complete replication of plasmid DNA
containing the SV 40 replication origin (Li and Kelly, 1984). This in vitro replication
reaction requires only one viral protein, SV 40 Large T Antigen (Li and Kelly,
1984). This system has led to identification of several proteins required in
mammalian DNA replication (reviewed in Waga and Stiliman, 1998, Hickey and
Malkas, 1997).
Replication Protein A
Human replication protein A.(RPA) is a single-stranded DNA-binding
protein that exists as a heterotrimeric complex consisting of subunits with apparent
masses of approximately 70, 34, and 11 kDa (Wold and Kelly, 1988, Fairman and
Stillman, 1988, reviewed in Waga and Stillman, 1998). p70 binds to the primase
subunits of poi ct-primase and the heterotrimeric complex binds to SV 40 T Antigen,
both in support of the interaction required for the assembly of the primosorne (Kenny
et al., 1990). The human p70 alone can bind single-stranded DNA, but it cannot
support DNA replication in vitro. The 32-kDa subunit has been observed to show an
S-phase-specific phosphorylation suggesting cell-cycle dependent regulation of RPA
(Din et al., 1990).
Replication Factor C
Replication factor C (RFC) is conserved in all eukaryotes studied. It is one of
the key proteins involved in loading the replicative polymerases to create the
replication fork (reviewed in Waga and Stiliman, 1998). Human RFC is a complex offive subunits, p140, p40, p38, p37, and p36 (Bunz et al., 1993, Pan et al., 1993), and
it preferentially binds to primer-template junction created by the annealing of an
oligonucleotide to single-stranded DNA. or by synthesis of a DNA primer on a
single stranded DNA template or nicked duplex DNA (Tsurimoto ci al., 1990). It
acts as DNA-dependent ATPase that is stimulated further by PCNA (Tsurimoto et
al., 1990). RFC's main role in replication is to load the trimeric, ring-like structure of
PCNA onto DNA at a primer-template junction or to load it onto a nicked site in
duplex. RFC-catalyzed PCNA loading is a necessary event preceding the assembly
of pol S onto template DNA to form a processive holoenzyme (Tsurimoto and
Stillman, 1991, Waga and Stillman, 1994). Mutational analysis shows distinct
regions of the p140 subunit that are responsible for DNA and PCNA binding
(Fotedar etal., 1996, Mossi etal.. 1997). The subunits of RFC show very high
sequence and functional similarity to replication proteins known in E. co/i and
bacteriophage T4 as clamp-loading proteins (ODonnell et al., 1993, reviewed in
Waga and Stillman, 1998).
Proliferating Cell Nuclear Antigen
Proliferating cell nuclear antigen (PCNA) is the DNA polymerase clamp. It
forms a homotrimeric complex and functions as a DNA polymerase accessory factor
(reviewed in Jonsson and Hubscher, 1997, Kelman, 1997). These proteins exist as
stable trimers that form a closed ring with a hole in the center where the duplex DNA
can slide through. It functions as a processivity factor for pol S during DNA
replication. PCNA can be loaded onto the DNA by RFC in an ATP-dependent
manner (Tsurimoto and Stiliman, 1991). The variety of interactions of PCNA with
other DNA metabolism proteins suggests that PCNA is a central factor for the
coordination of DNA replication, DNA repair, epigenetic inheritance, and cell cycle
control (Waga and Stillman, 1998).20
Enzymes Participating in RNA Primer Removal
Human FEN 1 is a single polypeptide of 46 kDa with a 5'3'
exo/endonuclease activity that is required for Okazaki fragment maturation
(reviewed in Bambara etal., 1997, Waga and Stiliman, 1998). Biochemical studies
shown that FEN 1 functions specifically to remove the RNA primer attached to the 5'
end of each Okazaki fragment (Murante etal., 1992, Turchi and Bambara, 1993).
When provided with a flap structure containing a 5' segment of DNA or RNA that is
not paired to template DNA, FEN 1 efficiently cleaves at the branch point, releasing
the unpaired segment (Harrington and Lieber, 1994). An Okazaki fragment that is
completely annealed to a single-stranded DNA cannot be degraded by FEN1 alone
but a ribonuclease in addition to FEN1 is required (Turchi ci al., 1994).
As with FEN 1, RNase HI is thought to be involved in the removal of RNA
primers during Okazaki fragment synthesis (Turchi et al., 1994). It
endonucleolyticaly cleaves RNA that is attached to the 5' end of a DNA strand, such
as in an Okazaki fragment, leaving a single ribonucleotide on the 5' end of the DNA
strand (Turchi et al., 1994, reviewed in Waga and Stillman, 1998)
DNA Helicase
DNA helicases promote the processive unwinding of duplex DNA. This
unwinding needs to occur at the DNA replication fork to create templates for the
polymerases (reviewed in Waga and Stillman, 1998). SV 40 large T antigen
functions as the replicative DNA helicase in the in vitro replication, but the helicase
involved in cell chromosome replication is still not defined, although several
mammalian helicases are identified to be involved in replication (reviewed in Waga
and Stiliman, 1998). Mouse helicase B is suggested to be involved in a process
during replication that does not determine the elongation rate of the fork (Matsumoto21
et al., 1995).The proteins that most resembles SV 40 Large T antigen in its structure
are the mini-chromosome-maintanance proteins. These proteins are essential
components of the prereplication complex established prior to S-phase at origins of
DNA replications (Kubotaet al., 1995,Todorovet al., 1995).This protein complex
is suggested to be a hexamer containing equal amounts of each of the six proteins,
typical of the replicative helicases from other organisms, and it was observed to
function as a replicative DNA helicase at the cellular replication fork (reviewed in
Waga and Stillman,1998,Tye,1999).
DNA Ligase
DNA ligase I has been shown to participate in SV 40 DNA replicationin
vitrofor the maturation of daughter DNA molecules into closed circular form I DNA
(Waga and Stillman,1994).Human cells with defects in DNA ligase I indicated the
enzyme involvement in thein vivoDNA replication process (Hendersonet al., 1985,
Barneset al., 1992).It is suggested that DNA ligase I functions to join the Okazaki
fragments during replication.
Synthesis of Leading and Lagging Strand
Li and Kelly(1984)developed the first mammalian-based DNA replication
system that successfully initiated DNA synthesisinvitro. This system requires two
viral components, the viral replication origin DNA sequence and SV 40 large T
antigen. T antigen recognizes and binds to the viral replication origin, and as
mentioned before it also has a helicase activity that melts the DNA in the replication
origins (Fanning and Knippers,1992).Theinvitro SV 40 DNA replication system
has been tremendously beneficial in understanding of the processes taking place in22
leading and lagging strand DNA synthesis in mammalian cells (reviewed in Hickey
and Malkas, 1997, Burgers, 1998, Bambaraet al.,1997, Waga and Stillman, 1998).
Synthesis of the leading strand involves the viral protein large T antigen
binding the viral DNA sequence origin and utilizing a 3'5' helicase activity to
separate the strands to create two replication forks (Li and Kelly, 1984). Unwinding
of the origin by SV 40 large T antigen is stimulated by the replication protein A
(RPA) (Wobbeet al.,1987, Wold and Kelly, 1988). After unwinding, each leading
strand is primed by RNA primers generated by the primase subunits of DNAp0!a
(Wang, 1991). The polymerase subunit of DNA pol a then adds a stretch of
deoxyribonucleotides to the RNA primer. Replication factor C (RFC) then initiates a
reaction which is called polymerase switching (Waga and Stillman, 1994). RFC
dissociates from DNA pol a-primase complex in an ATP-dependent process and
assembles proliferating cell nuclear antigen (PCNA) in the region of the primer
terminus.
In thein vitroSV 40 replication system, priming by DNA p01 aprimase and
then the switching to DNA polymeraseoccur similarly on both the lagging and
leading strands during DNA synthesis (Wagaet al.,1994a). However, synthesis of
lagging strand requires a lot of polymerase switching (Malkas, 1998). Nevertheless,
polymerase switching was found to be a necessary prerequisite for complete gap
filling in the lagging strand synthesis (Wagaet al.,1994a). Okazaki fragment
intermediates consist of RNA primer averaging about 10 nucleotides in length,
which was extended with 10-20 additional deoxyribonucleotides (Nethanelet al.,
1992). Because Okazaki fragment intermediates are made in the absence of ATP,
and RFC requires ATP for polymerase switching, it was thought that the 10 20
additional deoxyribonucleotides in the intermediates were added by DNA poi a-
primase before the switch (reviewed in Bambaraet al.,1997). An additional 10-20
nucleotides are added prior to the position of the next downstream RNA primer after
loading of PCNA and DNA pol ö (polymerase switching). It is thought that there23
would be further extension of the upstream primer during or after removal of the
initiator RNA and possibly nick-translation synthesis through the first
deoxyribonucleotides of the downstream primer (reviewed in Bambarael al.,1997).
RNase Hi then endonucleolytically cleaves the initiator RNA one nucleotide
upstream of the RNA-DNA junction (Turchiet al.,1994). The remaining
ribonucleotide is removed by FEN1/RTH1 (Wagaet al.,1994a, Turchietat1., 1994).
The joining of adjacent Okazaki fragments to complete lagging strand synthesis is
mediated by DNA ligase I (Turchi and Bambara, 1993).
DNA Replication Factories
In eukaryotes, DNA synthesis appears to occur within replication foci
(reviewed in Jackson, 1995). Each replication foci contain many replicons, and
within them DNA synthesis is mediated by a single mega complex of proteins
(Hozaket al.,1993). Multiprotein replication complex has been purified, and this
multicomplex was fully competent to replicate DNA in vitro (Malkaset al.,1990,
Applegreenet al.,1995, reviewed in Malkas, 1998). The human multiprotein
replication complex can be analyzed by sucrose gradient analysis and was observed
to have a sedimentation coefficient of 18 S.
Replication foci assemble in cells in a cell-cycle-dependent manner; they
initially appear in the late Gi phase and are maintained throughout S-phase (Hozak
et al.,1994). There are defined characteristic patterns of DNA synthesis during S-
phase that suggest a specific S-phase program for replication (Hozaket al.,1994,
reviewed in Jackson, 1995, Malkas, 1998). Temporally coordinated activation of
different sets of replicons occurs throughout S-phase, and there is evidence that the
sites are influenced by nuclear structure. These replication factories also appear to be
associated with the nuclear matrix (Hozakel al.,1993).24
DNA Replication and the Cell Cycle
DNA replication occurs only once per cell cycle. The regulation of DNA
replication is mediated by a variety of proteins including cyclin proteins, cyclin-
dependent protein kinases (cdks), cyclin dependent protein kinase inhibitors (CDIs),
oncogene and tumor suppressor gene products, and some transcription factors that
are thought to enhance the utilization of replication origins (reviewed in Hickey and
Malkas, 1997). An overview of how DNA replication is regulated in the cell-cycle is
summarized below.
Cyclin D associated with either cdk4 or cdk 6 (Matsushimeet al.,1992,
Meyerson and Harlow, 1994) and cyclin B associated with cdk2 (Dulicet al.,1992,
Koffet al.,1992) are thought to regulate cells' progression from Gi to S-phase.
Cyclin D-cdk4 complex regulates the passage of cells through START, the Gi
checkpoint that commits cells to DNA synthesis (Matsushimeet al.,1992, Geng and
Weinberg, 1993). Several interactions of cyclin D with other proteins modulate its
activity, which in turn would regulate cell-cycle progression. p27 tumor suppressor
gene expression can inhibit the cyclinD-cdk4 kinase activity and prevent cells from
progressing into S-phase and inititating a new round of DNA synthesis (Toyoshima
and Hunter, 1994). Transcription factor TGF-is also known to reduce the cyclin D-
cdk4 complex activity (Toyoshima and Hunter, 1994). Interaction of the
retinoblastoma (Rb) and the c-myc proteins with the gene encoding cyclin Dl
upregulates cyclin D expression (Mulleret al.,1994, Marhin cial.,1996). In viva, it
has been observed that cyclin D-cdk4 phosphorylates Rb (Hortonet al.,1995,
Connell-Crowley cial.,1997). In Gi cells, the activation of transcription factor E2F
from the Rb-E2F complex can be conferred by cyclin D-cdk4-dependent
phosphorylation of Rb. Inactivation of Rb by phosphorylation enables cells to
progress into S-phase and initiate DNA synthesis (Wuet al.,1996, reviewed in
Weinberg, 1995).25
Another cyclin, cyclin E, is required to complete cell progression through Gi
and enables the cells to traverse the GuS-phase border (reviewed in Heichman and
Roberts, 1994, Ohtsuboet al.,1995). The cyclin E-cdk2 complex is essential for
progression into S-phase since it is known to stimulate the transcription of genes that
are required for S-phase (Leeset al.,1992). The cyclin-dependent kinase inhibitor
p27 can inhibit the cells from crossing through the GuS border by binding to the
cyclin E-cdk2 (Polyaket aL,1994, Slingerlandet al.,1994).
In S-phase, cyclin A is essential for progression through the phase, and it is
also required in the molecular processes required to support progression of cells
through the G2/M border (Paganoet al.,1992). Cyclin A-cdk2 complex is thought to
down-regulate the genes that are required for G 1/S progression which were activated
by cyclin E-cdk2 in early S-phase, through transcriptional inactivation (Dynlachtet
al.,1994, Kreket al.,1994). Cyclin A is degraded following G2/M transitions
(Wanget al.,1992).
Cyclin B interacts with a cdc2-related kinase to form mitosis-promoting
factor (MPF) that drives the cells through mitosis, and subsequently enables cells to
form preinitiation complexes (Adachi and Laemmli, 1994). There is evidence to
suggest that cells become competent to replicate DNA during the M phase of the cell
cycle (Adachi and Laemmli, 1994), although the cells do not commit to DNA
synthesis until they have progressed through M and START (Roberts, 1993). Cyclin
B-cdc2 complex is maintained at the inactive state through phosphorylation of Tyr-
15 and Thr-14 on the cdc2-related kinase molecule (reviewed in Kinget al.,1994,
Draettaet al.,1988). The kinase is activated by dephosphorylation carried-out by
Cdc25 phosphatase at the end of G2 phase (Gautieret al.,1991). At the end of M-
phase cyclin B-cdc2 complex is proteolytically inactivated to allow the cells to
progress into the Gi phase (Murrayet al.,1989, Gallant and Nigg, 1992).
Secondary levels of control for cell cycle progression are through a series of
proteins known as cyclin-dependent kinase inhibitors (CDIs) that are thought to bind
directly to the cyclin-cdk complexes and inhibit their activity (reviewed in Hickey26
and Malkas, 1997). Some of these CDIs are p15, p16, p21 and p27. p21 is known to
bind and inhibit the activity of cyclin D-cdk4, cyclin E-cdk2, cyclin A-cdk2 and
PCNA (Xionget al.,1993, Wagaetal.,1994b). p21 binding to PCNA inhibits the
PCNA-mediated stimulation of DNA polymerase ö activity is evidence of a direct
regulation of DNA replication machinery by a cell cycle-related protein. p21
expression is induced by p53, which is known to be induced in response to DNA
damage (El-Deiryetal., 1993). This observation correlates with other observations
showing that DNA damage can arrest cells during S-phase. P27, another CDI, is
capable to prevent the initiation of DNA synthesis by binding and inhibiting cylin E-
cdk2 with the net effect of preventing cells from crossing the GuS border (Polyaket
al.,1994, Slingerlandet al.,1994).
DNA Replication Fidelity
The high fidelity of DNA replication is ensured by three main factors: the
high intrinsic accuracy of DNA polymerases in inserting and selecting for correct
template-dNTP base pairing, the exonucleolytic proofreading activity associated with
the replicative polymerases and the actions of mismatch repair proteins that correct
mismatches in the newly replicated DNA (reviewed in Kunkel and Bebenek, 1988).
The underlying principle of polymerases selectivity in discriminating for
correct base pairing of template and incoming dNTP is the precise geometry of
Watson-Crick base pair (reviewed in Echols and Goodman, 1991). Other than the A-
T and G-C base pairs, all other base pairing combinations have altered geometries. It
is thought that DNA polymerase active site prefers the correctly base paired Watson-
Crick geometry over the non-Watson and Crick base pairs such as wobble base-pair
structures. However, the free energy differences of matched versus mismatched base
pairs in aqueous solution could not account for the insertion accuracy observed for
most DNA polymerases, which is in the range of 1 O to 1 O, since the free energy27
differences are only approximately ten-fold. It has been suggested that the hydrogen-
bonded water molecules are excluded from the transition state for complementary
base pairs within the active site, and the active site exclusion of water may increase
the base pair free energy (Kunkel, 1 992b). Other factors have been suggested to
affect nucleotide discriminations. These include base stacking and specific amino
acid interactions with the DNA template-primer in the polymerase active site
(reviewed in Echols and Goodman, 1991, Goodman, 1997).
Polymerization of a single nucleotide can be divided into several steps as
shown in Figure 1.2 (taken from Johnson, 1993). The kinetic mechanism for DNA
polymerization has been derived mainly from prokaryotic polymerases DNA pol I
(Kienow Fragment) and T7 DNA polymerase (reviewed in Kunkel, 1 992b, Johnson,
1993). More recent kinetic studies on mammalian DNA polymerases have shown
that the mechanism of single base pair polymerization in mammalian poi S and y
follows similar mechanism to that of the prokaryotic DNA polymerases (Einolf and
Gengerich, 2000, Graveset al.,1998). From kinetic data, it is suggested that
nucleotide selectivity of polymerization is derived from several stages in the reaction
cycle. In T7 DNA polymerase, correct dNTP is bound with much higher affinity than
incorrect dNTP (Pateletal.,1991). The selectivity, which is defined as the ratio of
kcat/KMof correct versus incorrect polymerization, is about 10,000 (Pate!et al.,
1991). Polymerization is much slower for incorrect dNTP than for correct dNTP
(Pate!et al.,1991). Selectivity is conferred after dNTP binding but preceding the
phosphodiester bond formation (Pate!el al.,1991). It is thought to involve enzyme-
dNTP confonnational changes that positions dNTP for catalysis termed induced fit
selectivity (reviewed in Johnson, 1993). In the case of incorrect dNTP binding to the
enzyme-DNA complex, slower phosphodiester bond formation can be observed
(Wongetal.,1991). Among DNA polymerases that have been studied there are






















Figure 1.2. Kinetic Mechanisms for DNA Polymerization. The values in bold are
obtained from T7 DNA polymerase (adapted from Johnson, 1993). Kinetic
parameters inside parentheses are from fetal calf thymus DNA polymerase 6 in the
presence of PCNA (Einolf and Guengerich, 2000).
DNA pol 6 polymerize DNA at a slower rate than T7 DNA polymerase (as shown in
Fig. 1.2). Pol 6 has much lower Kd for dNTP, and in the presence of PCNA, the
DNA does not dissociate from pol 6 as often as in case of T7 DNA polymerase.
Moreover, it is believed that different mispairs can also modulate the selectivity of
DNA polymerases (reviewed in Johnson, 1993, Kunkel and Bebenek, 2000).
Proofreading functions add an additional 100-fold to the fidelity of DNA
polymerases. This number is obtained from studies of polymerases in which the
proofreading activity has been compromised either by addition of nucleoside
monophosphate, or a high concentration of dNTP, or site-directed mutagenesis of a
residue that is essential for proofreading activity (reviewed in Kunkel, 1 992b). The
kinetics of DNA misincorporation comes largely from studies with exo T7 DNA
polymerase (Wong et al., 1991) and E. coli pol 1 Kienow fragment (Eger and
Benkovic, 1992, Dahlberg and Benkovic, 1991). In Figure 1.3 it is shown that the
rate of insertion and polymerization from a correctly paired terminus is faster29
compared to the dissociation rate or excision from a correct terminus. However,
when misincorporaton has occurred, the rate of mismatch extension is slow while the
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Figure 1.3. Kinetics of Exonuclease Proofreading. The kinetic constants are from
Pateletal.(1991). Donlinet al.(1991) and Wongetal.(1991) for T7 DNA
polymerase. The values and kinetic scheme were summarized previously (Johnson,
1993).
In DNA pol I (Kienow fragment), a second conformational change after
formation of phosphodiester bond is thought to follow misincorporation (Dahlberg
and Benkovic, 1991) that was not observed for T7 DNA polymerase (Wonget al.,
1991). The mechanistic difference could be explained by the functional difference
between the two enzymes. DNA pol I (Klenow fragment) functions as repair
polymerase instead of replicative polymerase like the T7 polymerase. It was also
shown that exonuclease activity of mismatched termini may be enhanced
significantly by instabilities of local primer termini (Bloomet al.,1994). In T7 DNA
polymerase, the excision of mismatched termini occurs faster than matched
nucleotide-DNA termini with rate-limiting translocation of terminal nucleotides to
exonuc lease active site (Figure 1.3). The fast rate of translocation back to30
polyrnerase site prevents the exonuclease activity from removing additional
nucleotides from the termini (reviewed in Johnson, 1993, Kunkel and Bebenek,
2000). It has been observed that rates of extension from different mismatches are
varied (Perrino and Loeb, 1989, Creightonet al.,1992).Different mismatch termini
probably modulate the exonuclease proofreading efficiency to some degree.
Mismatch repair associated with newly replicated DNA contributes to DNA
replication fidelity, as not all mismatches are corrected by exonucleolytic
proofreading. Some mispairs, such as G/T wobble pair, do not distort the helix
significantly and are known to be able to be extended by polymerases (reviewed in
Jiricny, 1998). Other errors that might not be corrected by exonuclease proofreading
are loops created by primer-template misalignrnents. These loops are the substrate
for mismatch repair (Jiricny, 1998). Mismatch recognition is the initial step for
repair. hMutSa, composed of hMSH2/6 complex, is thought to preferentially bind
base-base mismatches and loops of one nucleotide (Palomboet al.,1995, Palomboet
al.,1996, Acharyaet al.,1996), and another complex, hMutS, which is composed
of hMSH2/3, is thought to recognize other loop structures (Palomboetal.,1996,
Acharya etal.,1996). hMLHI/hPMS2 and hPMSI are the human homologs of the E.
coil MutL protein (Li and Modrich, 1995). hMLH1/hPMS2 (hMutLa) complex is
found to interact with hMutS complexes that is bound to the mismatched or looped
DNA (Mattonet al.,2000). No biochemical role has been defined for the third
human homolog of E. coil MutL, hPMS1 protein, although there is evidence for
interaction between hMLH1 and hPMS I to form hMutLt3 complex (Raschleet al.,
1999). Other proteins that are thought to participate in mismatch repair processes are
PCNA and polas well as the single-stranded DNA binding protein, RPA (reviewed
in Jiricny, 1998, Kolodner, 1995).31
DEOXYRJBONUCLEOSJDE TRIPHOSPHA TES AND MUTA GENESIS
dNTP imbalance, produced in cells through a variety of means, such as
exposure to mutagens, administration of drugs that disrupt the enzymes involved in
dNTP metabolism, mutations affecting dNTP metabolic enzymes, or addition of
bases or nucleosides to the growth medium, has been widely documented to have
various effect on the cells' mutation frequency (reviewed in Kunz and Kohalmi,
1991, Kunzet al.,1994, Meuth, 1989). In some cells specific dNTP perturbations
change the observed mutation frequency, while in other cells no effects on mutation
frequency were observed (reviewed in Kunz and Kohalmi, 1991, Kunzet al.,1994,
Meuth, 1989).
In vivo, the effects of dNTP imbalance have been studied through sequencing
of mutants. Mechanisms of mutations causing dNTP imbalance are thought to occur
through misinsertions of the dNTP that is higher in concentration compared to other
dNTPs during replication and through the "next-nucleotide effect" (Kunkel, 1988),
which is the term used for the observed preference of misincorporation when the
next nucleotide is present at high concentration. It is thought that in a situation where
excess nucleotide is present during replication, two mechanisms leading to next-
nucleotide effect can be envisioned. First, increase in nucleotide concentrations can
increase the probability of extending a mismatched terminus, and second, enhanced
polymerization rates can reduce the probability that a mismatched terminus is
corrected by the exonuclease proofreading. Both effects of increased nucleotide
concentrations, increase in substitution mutation and next-nucleotide concentration,
were observed in vivo; however, there are some base pair changes that sometimes
predominates among mutants sequenced but are not explained by the two effects
(reviewed in Kunz and Kohalmi, 1991). Other mechanisms that can also generate
mutations in condition of dNTP imbalance involved template-primer misalignment
(Kunkel, 1990). Most of the resulting mutations involving this mechanism would32
result in frameshift mutations. It is not evident to what extent template-primer
misalignment contributes to mutations induced by imbalanced dNTP in vivo.
OBJECTIVES
The main focus of this thesis is to explore the relationship between dNTP
levels during replication and the observed spontaneous mutation frequency in vitro
and in vivo. Specifically, three questions involving dNTP levels and DNA replication
fidelity will be addressed:
1.What is the effect of dGTP underrepresentation on replication fidelity in
mammalian cells in vitro? What is the effect of different dNTP pool
levels obtained from immortal and normal diploid cells lines on the
observed mutation frequency in vitro?
2.Is there a modulation of dNTP levels during S-phase in mammalian cells
in vivo? Is there a difference in the rates of DNA replication at different
times during S-phase in mammalian cells?
3.Is there a difference in the in vivo spontaneous mutation rates between
genes that are replicated at different time during S-phase in mammalian
cells? If there are differences, do they correspond to differences in dNTP
levels or DNA replication rates during S-phase?
The first question, which will be addressed in Chapter 2, deals mostly with
the observations of underrepresentation of dGTP in almost all cell lines studied
(reviewed in Mathews and Ji, 1992). However, the dNTP pool measurements
obtained were mostly from immortal or somatic cell lines; therefore, studies on the
effect of different dNTP pools measured from immortal cell lines derived from
cancer cells and normal diploid cell lines derived from somatic cells on replication
fidelity in vitro were also done. Most mammalian tissues are composed of resting
cells not directly relevant to this in vitro study. These resting cells have negligible de33
novonucleotide synthesis (Amer and Eriksson, 1995) and dNTP pools. However, it
has been documented that in cancer cells nucleotide synthesis enzymes, such as
thymidine kinase, are present at higher levels than their levels in cycling somatic
cells (Gordon et al., 1968). Regulation of enzymes involved in nucleotide synthesis
has also been reported to be altered in cancer cells (Hengstschlager et al., 1994,
Hengstschlager et al., 1996). These could provide the basis for the different levels of
dNTP pools between the two kinds of cell lines. Whether the difference in dNTP
pooi levels extracted from the immortal and normal diploid cell lines can modulate
DNA replication fidelityin vitrois evaluated in the study.
It has been proposed that different ratios of dNTP pools during S-phase in
germ line cells could account for the existence of isochores (Wolfe et al., 1989),
approximately 300-kb regions in mammalian chromosomes that have similar G+C
contents in DNA base pair composition (reviewed in Sabeur et al., 1993). The dNTP
pool levels of HeLa cells during S-phase were evaluated, as presented in Chapter 3.
Concomitant evaluation on DNA synthesis rates at specific times during S-phase
were also evaluated to examine the relationship between the measured dNTP pool
levels andin vivoDNA synthesis rates in HeLa cells.
In Chapter 4, the effect of the time a specific gene is replicated in S-phase is
evaluated. Modulation of dNTP pool levels and DNA synthesis rates could affect the
mutation frequencyinvitro; therefore, the effect of replication time during S-phase,
which corresponds to modulation of dNTP pools and DNA synthesis rate in HeLa
cells, on spontaneous mutation frequency in vivo was evaluated.
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CHAPTER 2
EFFECTS OF BIOLOGICAL DNA PRECURSOR POOL ASYMMETRY
UPON ACCURACY OF DNA REPLICATION IN VITRO
Stella A. Martomo and Christopher K. Mathews




Deoxyguanosine triphosphate (dGTP) is underrepresented among the four
common deoxyribonucleoside triphosphates (dNTPs), typically accounting for 5 to
10 percent of the total dNTP pool. The research conducted in this section will
address whether this pool asymmetry affects the fidelity of DNA replication by use
of an in vitro assay in which an Ml 3 phagemid containing theEscherichia coli
lacZa gene and an SV 40 replication origin is replicated by extracts of human cells.
By monitoring reversion of either a TGA or a TAA codon within the lacZa gene,
different pattern of mispairing events leading to mutations was observed in
replication reaction with "biologically biased" dNTPs, representing the estimate of
the concentrations in HeLa cell nuclei. However, replication reaction with biased
dNTPs is not significantly more accurate than replication reaction containing four
dNTPs at equimolar concentrations (100 tM). During replication at biased dNTP
levels, mutations at the site 5' to C in the template strand for the TGA triplet had a
tendency to be less frequent than seen in equirnolar reaction mixtures, suggesting
that extension from a mismatch at this site is relatively inefficient, when dGTP is the
next nucleotide to be incorporated. Furthermore, an excessively low concentration of
one dNTP is not as mutagenic in replication reactions with biased dNTP
concentrations as an excessively high concentration of a single dNTP. The dNTP
concentrations in non-transformed human fibroblasts were also estimated, and it was
found thatin vitroreplication at these levels caused considerably fewer mutations
than that observed under equimolar conditions (100 tM each dNTP). Replication
rates are decreased somewhat at these non-transformed fibroblast concentrations,
inferring an efficient polymerization rate at this lower dNTP concentrations.
Replication fidelity is enhanced in replication reactions with dNTPs at non-
transformed fibroblast concentrations, presumably from much lower efficiency of52
mismatch extensions in this reaction than in replication reactions with higher,
although equimolar, dNTP concentrations.
INTRODUCTION
Intracellular concentrations of the four deoxyribonucleoside triphosphates
(dNTPs) are normally controlled within narrow limits, through regulation of
biosynthetic and degradation rates (reviewed in Reichard, 1988). Perturbations of the
"normal" dNTP balance have been documented to have divergent effects in cells,
and most of them lead to an increase in spontaneous mutation frequency (reviewed in
Kunz and Kohalmi, 1991; Reichard, 1988). However, the specific effect of
unbalanced dNTP pools in cells on replication error frequency is not always clear.
Perturbations of dNTP pools in vivo have been achieved by several means, such as
adding nucleobase to increase dNTP pools via the salvage pathway or adding drugs
to inhibit an enzyme in dNTP metabolism (Meuth, 1989). Also, strains that have a
defect in dNTP pool metabolism and therefore have either an increase or decrease in
one or more pools as compared to normal cells have beenstudied to give an insight
on the effect of unbalanced dNTP pools on mutation frequency.Since most of the
treatments to achieve pool perturbation are not specific to one INTP, it is difficult to
relate the observed effect on DNA replication accuracy (reviewed in Meuth, 1989).
In vitroDNA replication experiments have shown that dNTP concentration is
an important determinant of DNA pofymerase fidelity (Kunkel,1992). Increasing the
concentration of one nucleotide in the replication reaction can increase mutation
frequency significantly. Under certain conditions, decreasing the concentration of
one or more nucleotides has also been shown to increase theobserved mutation
frequency (Roberts and Kunkel, 1988; Perrino and Loeb, 1988; BebeneketaL,
1992).53
Given the extent of dNTP pools' effects on replication fidelity, it is quite
surprising that whole cell dNTP pooi measurements of various mammalian cells in
culture are not symmetric. dGTP is almost always underrepresented (reviewed in
Mathews and Ji, 1992). dNTP pool measurement from frozen rat embryo also shows
that dGTP is lowest in concentration, suggesting that whole cell dNTP pools
measured in cultured cells resemble the concentrations found in intact cycling and
living cells (Moleet al.,1998). Previously Dr. Mathews' laboratory also has been
able to measure the dNTP pool concentrations of HeLa cell nuclei, and they
approximate the molarity of the whole cell pool measurements (Leedset al.,1985).
Measurement of dNTP pools in cells repesents the level of the cells' steady
state dNTP concentrations as the result of the difference between the rate of their
production and use or degradation. Therefore, it is questioned whether dNTP pool
measurement resembles the actual dNTP concentrations available at the replication
fork. One issue that has been put forth is the possibility of compartementation of
pools in eukaryotic cells. However, experiments that addressed dCTP pool
compartementation showed different results in the different cell lines (Xuet al.,
1995, Nicander and Reichard, 1983). Moreover, in vivo experiments (Meuth, 1989)
showed a clear indication that an increase in the measured dNTP pools produced the
expected kinds of substitution mutations, suggesting similar increase in the specific
pools at the replication fork. Based on Meuth' s observations, the experiments
presented here were based on the premise that the measured nuclear dNTP pools
probably represent a good approximation of the dNTP concentrations available at the
replication forks in eukaryotic cells.
To test the effects of biologically biased dNTP concentrations of HeLa cell
nuclei on DNA replication accuracy, human cell extracts were analyzed in the in
vitro assay for reversion of an M13 phagemid which had an SV 40 origin of
replication in reaction mixtures containing either biologically biased or equimolar
dNTP concentrations. Mutation frequency is defined as the number of revertants out
of total number of plaques counted. Revertants arise when an incorrectly base-paired54
dNTP is inserted opposite a DNA template and not proofread by the exonucleolytic
proofreading function associated with human replicative DNA polymerases. The
effects of underrepresentation of dGTP on proofreading activity on a rnisp air 5' to a
template C and on the higher probability of misincorporation opposite template C are
purposely addressed. These events were predicted to be the events most likely
influenced by the small size of the dGTP pool.
MATERIALS AND METHODS
DNA CONSTRUCTS, BACTERIAL STRAINS AND CELL LINES
Mutants of the phagemid M13mp2SV (Roberts and Kunkel, 1993) were used
which contained an SV 40 replication origin and the first 45 codons of Escherichia
co/i-galactosidase with 115 nucleotides of upstream sequence. A derivative of the
phagemid, which is designated M13mp2SV/opal7 in this study, contains an opal
codon at position 7 of the lacZa peptide and has been described before in Zhang and
Mathews (1995). Another derivative was made of the M13mp2SV phagemid,
M13mp2SV/ochre7, which was constructed by site directed mutagenesis of the wild
type Ml 3mp2SV using PCR (Ho et al., 1989). This construct contains an ochre
codon at position 7 and an AAC codon, which is a silent mutation at position 6.
Below is the sequence of the relevant region of M13mp2SV plasmid and its
derivatives, and introduced mutations are shown in bold.
Ml 3mp2SV/ochre7 was constructed by site-directed mutagenesis using PCR
(Ho et al., 1989). PCR primers used in the site directed mutagenesis were: MPA (1),
5'GGA CTA TGG TTG CTGAC; MPB (2), 5GAA GATCGCACTCCA GC;55
codon number of lacZet




MPC (3), 5GGC CAG TTA GTT CGT AAT CAT G and MPD (4), 5GAT TAC GAA
CTA ACT GGC CGT C. Primers were used as diagrammed:
5,
5,
The first sets of amplification were with primers 1 and 3 and also primers 2 and 4
with the MI3mp2SV DNA template. The second set of amplification was with
primers 1 and 2 and the DNA fragments generated from the first sets of amplification
were used as template. The resulting gene fragment was digested and ligated back
into M13mp2SV phagemid.
Eschericia coliCSH5O, NR9 162 and NR9099 were obtained from Dr.
Thomas Kunkel (NIEHS).E.coil NR1 1089 was kindly constructed by Dr. Roel
Schaaper (NIEHS). This strain is isogenic to CSH5O with an exception of having an
ochre suppressor at amino acid position 7 of LacZa. M13mp2SV/ochre7 gave a
medium blue phenotype when plated on E. coli NR11089. Prolonged incubation (30
hours or more) of Ml 3mp2SV/opal7 phagemid plated onE co/iNR1 1089 usually
results in a very light blue phenotype, which suggests a slow leaky phenotype of the
ochre suppressor for the opal codon at the same position. HeLa S3 and HCT 116 cell
lines were obtained from American Type Culture Collection (ATCC). HCT 116 cells56
are derived from a colon tumor and are defective in mismatch repair. HeLa S3 cells
were grown in S-MEM medium (Gibco BRL) supplemented with 5% fetal bovine
serum. HeLa cells were grown in suspension, and 1 L of cells was used for
preparation of extracts as described by Roberts and Kunkel (1993). HCT 116 cells
were grown in McCoy 5A medium supplemented with 10% fetal bovine serum. The
cellular contents of 40 150-mm plates were trypsinized and combined for preparation
of extracts.
REPLICATION REACTION
Preparation of Cellular Extracts
The human cell extracts preparation was essentially as described by Roberts
and Kunkel (1993). For extraction of spinner culture cells, 1 L of cells was harvested
at mid-log growing phase. The cells were pelleted at 1,500 rpm for 5 mm at 4°C in a
Beckman table-top centrifuge. The pellet was washed twice in ice-cold phosphate-
buffered saline (PBS: 8 gNaCl, 0.2 g KC1, 1.44 gNa2HPO4, 0.24 gKH2PO4in 1 L
double-distilled H20 (ddH2O), prepared as 1 Ox solution), followed by one wash in
cold isotonic buffer (20 mM HEPES-KOH (pH 7.8), 5 mM KC1, 1.5 mM
MgC12.H20, 250 mM sucrose and 1 mM DTT that was added just before use) and
one more wash of cold hypotonic buffer (20 mM HEPES-KOH (pH 7.8), 5 mM KC1,
1.5 mM MgCl2.H20, 1 mM DTT) before finally resuspending the pellet in a total
volume of 5 mL of hypotonic buffer. The cell suspension was transferred to a 7-mL
Dounce homogenizer (Kontes) on ice. The cells were allowed to swell in the
hypotonic buffer on ice for 60 minutes.
For extraction of HCT 116 cells, which were grown in plates, 40 1 50-mm
plates of log-phase growing HCT 116 cells were pooled. Each plate was trypsinized,57
and the cells were pooled into 4 separate 50-mL conical centrifuge tubes. The cells
were pelleted and washed as described above for cells grown in spinner culture. The
four tubes were pooled into one 50-mL conical centrifuge tubes for the hypotonic
buffer wash and resuspension. As with spinner cell extraction, the cells then were
transferred to the Dounce homogenizer in which they were allowed to swell in the
hypotonic buffer.
The next steps of extraction were identical for both the spinner and attached
cell cultures. The cells were lysed with two strokes of the tight fitting homogenizer,
and the extent of cell breakage was determined by adding 50 tL of trypan blue dye
solution (0.4% w/v, 1 M NaHCO3, filter sterilized) to 100 pL of cell suspension from
the Dounce homogenizer that were then examined using the light microscope. Lysed
cells would incorporate the trypan blue dye and would appear blue using the
microscope. Usually, four to six strokes were required to cause about 80% cell
breakage for HeLa cells, and ten to twelve strokes were required for HCT 116 cells.
The extracts then were transferred to a cold Corex centrifuge tube and
centrifugation was conducted at 3,000 rpm in a fixed-angle Sorvall SS 34 rotor for
10 minutes at 4°C to pellet the nucleus and the unbroken cells. The supernatant
fraction was transferred to another cold centrifuge tube and centrifugaion was
performed at 12,000 rpm in the same rotor at 4°C. The cleared supernatant fraction
was transferred to a clean tube, mixed and 10 tl was analyzed to determine the
protein concentration using the Bradford method. The rest of the extracts were
aliquoted into 500-tL Eppendorf tubes on ice that were immediately dropped into
liquid nitrogen and stored in 80°C. The extract usually had a protein concentration
of 10-20 mg/mL as determined by Bradford assay. Each aliquot was thawed and
centrifuged immediately before use at 14,000 rpm for 15 minutes in a fixed-angle
Eppendorf centrifuge at 4°C. The cleared supernatant was transferred to a clean
Eppendorf tube and then was ready for use in the replication reaction.
"Dialysed" HeLa cell extract was prepared by processing the thawed and
centrifuged extract through the clear Centri-sep column (Princeton Separation)58
according to manufacturer's instruction, and then through Microcon 3 centrifugal
separation (Millipore) at 10,000 rpm in a fixed-angle Eppendorf centrifuge for 10
15 minutes at 4°C immediately before the reaction.
In Vitro Replication Reaction
In vitro replication reactions using either HeLa or HCT 116 cell extracts were
essentially as described in Roberts and Kunkel (1993). SV 40 Large T antigen was
obtained from Molecular Biology Resources (MBR). Radioactive [a-32P]dATP or
dCTP tracer (1 000 cpm/pmol) was used only in confirming the replication activity
of the extracts preparation. No radioactive tracer was used in the actual experiments
where phages were plated to obtain mutation frequency. The replication reaction (25
tL) contains 30 mM HEPES-KOH (pH 7.8); 7 mM MgC12; 4 mM ATP; 200 lLM
each of CTP, GTP and UTP; dNTP (equimolar reactions contain 100 jM of each
dNTP and biologically biased dNTP concentrations refer to calculated HeLa cells'
nuclei concentrations as reported by Leeds et al. (1985), which are 60 j.iM dATP, 60
tM dTTP, 30 .tM dCTP and 10 tM dGTP); 40 mM creatine phosphate (Sigma); 100
mg creatine phosphokinase (Sigma)/mL; 40 ng of replicative form of the template
DNA;1tg SV4O T antigen; and75 jig protein of the extract. It is important to
use template DNA that has been purified through a CsC1/ethidium bromide gradient
following isolation by anion exchange chromatography (Qiagen). The reaction
mixture was incubated at 37°C for4 hours, and 25 tL of stop solution (2 mg
proteinase K!mL, 2% (wlv) sodium dodecyl sulfate (SDS), 50 mM EDTA; the
solution was made immediately before use) was added to the reaction which was
then incubated again at 37°C for 30 minutes. For determination of 32P incorporation,
10 pL from each reaction was spotted onto Whatman filter paper that had been
saturated with 5% trichioroacetic acid (TCA)/0.1 M Na2H2P2O7, and the paper was59
washed in 5% TCA!0. 1 MNa2H2P2O7twice for 15 minutes each at room
temperature and with 95% ethanol (EtOH) twice for 15 minutes each at room
temperature. The dried filter paper was then put into the scintillation vial with2
mL of scintillation coctail and counted. Otherwise the rest of the reaction mixture
was collected by adding 28 tL of precipitation mix (final concentration of 20 tg
carrier tRNA and 1 M ammonium acetate) and 100 tL of isopropanol. The DNA
was precipitated by incubating at 20°C for at least 20 minutes to overnight. The
DNA was collected through centrifugation, and purified through extraction with PEB
(100 mM Tris-HC1 (pH 8.0), 1 mM EDTA, 300 mM NaC1)-equilibrated phenol (2 x
100 .iL). The DNA was precipitated again and collected through centrifugation. It
was then digested with excessDpn I(NEB Biolabs) that was tested each time to be
active by digesting 40 ng of template DNA alone and by electroporation and plating
of theDpnIdigested DNA control onto the platingE.coil. Typically, 40 ng of
template DNA digested withDpnIyielded a total of10,000 plaques which
contribute to less than 0.5% of the total plaques typically yielded in a replication
reaction. Products of replication reaction with [a-32PIdNTP tracer can then be
characterized by restriction digest analysis(DpnI orMbo I),electrophoresed on 1%
agarose-0.5x TBE (0.089 M Tris-borate, 0.002 M EDTA pH 8.0 made as 5x stock
solution) gel for approximately 1-2 hours, following which the gel was dried and
autoradiographed. The digested DNA to be plated was precipitated again and
collected through centrifugation, dried and resuspended in TE buffer (10 mM Tris-
HC1 (pH 8.0), 0.1 mM EDTA).
Plating of the phages was done by electroporating the DNA into -'-0. 15 x1010
E. coli NR9 162 (mutS). The electroporatant (the calculated amount of DNA
electroporated intoE. coilNR9162 and resuspended in 1 mL of LB (10 g tryptone, 5
g yeast extract, 10 g NaC1 in 1 L of ddH2O, autoclaved)) was plated simultaneously
with E. coil CSH5O or NR1 1089 cells that would produce a lawn of a-
complementation indicator, cells. Minimal media plate (25 mL/plate, 1 00-mm plates;
1 L of minimal media plate was made up of 15 g Bacto agar in 800 mL H20,60
autoclaved; 200 mL of 5x salt (1 g MgSO4.7H20, 10 g citric acid (anhydrate), 50 g
K2HPO4, 7.5 g Na2HPO4.2H20, in 1 L H20, autoclaved); 20 mL of 20% (w/v)
glucose, filter sterilized; and 0.5 mL of 10 rng/mL thiamine hydrochloride, filter
sterilized) was used with 2.5 mL of prewarmed (45°C) soft agar (0.8% (w/v) agar,
0.9% (w/v) NaC1, autoclaved) aliquoted together with 25 pL of 24 mg isopropyl
thiogalactoside (IPTG)/mL H20 (filter sterilized, store frozen) and 50 tL of 50
mg/rnL of 5-bromo-4-chloro-3-indolyl-B-D-galactoside (X-Gal) inN,N-
dimethylformamide (stored at 20°C, avoid light exposure), and ready to be mixed
with the electroporatant and 300 L log-phase growing E. coli CSH5O or NR1 1089.
Plating of all the electroporatant (usually onto 50-60 minimal media plates) was
completed within 30 minutes after electroporation to avoid the release of phage
particles while they were still in solution. Usually the amount of DNA to be plated
was calculated to yield about 2000-4000 plaques/plate in order to be able to clearly
see the mutant plaque. Plates with very dense plaques usually give an
underestimation of the total mutation frequency since not all of the plague estimated
from the counting plates (1 to50 or 100 dilution phage plated to give the total
number of plaques observed) are formed when there is more than 7000
plaques/plates.
Sequencing of the revertants was done by the Center for Gene Research and
Biotechnology (CGRB) sequencing facility at Oregon State University. Each blue
plaque was diluted into 0.9% NaCl solution and replated twice until isolated blue
plaques could be picked from the E. coli lawn. The single stranded Ml 3 DNA from
each revertant was isolated according to Del Sal et al., (1989) with some
modification. Briefly, to 1 mL of supematant collected of previously infected culture
(the phage culture was collected by centrifuging at 14,000 rpm in an Eppendorf
microcentriftige for 10 minutes to remove bacteria), 0.25 mL of 15% (w/v)
polyethylene glycol (PEG)/ 2.5 M NaCl was added. The solution was incubated for
more than 5 minutes at 4°C and centrifuged at 15,000 rpm in an Eppendorf
centrifuge for -2 minutes. The pellet was then resuspended in 690 tL of ddH2O, and61
100 L of 1 M Tris-HCI (pH 8.0), 100 jiL of 0.5 M EDTA, and 10 tL of 10 mg/mL
proteinase K solution were added before the mixture was incubated at 37°C for 30
minutes. Next, 100 tL of 10 x cetyltrimethylammonium bromide (CTAB) was
added, and the mixture was incubated further for 10 minutes at 3 7°C. The sample
was centrifuged at 15,000 rpm in an Eppendorf centrifuge for 10 minutes, and the
pellet was resuspended in 300 tL of 1.2 M NaC1, 0.75 mL of 100% EtOH was
added, and the sample was incubated at 20°C for at least 20 minutes before
collecting the DNA by centrifugation. The pellet was washed in 70% EtOH (v/v),
dried and resuspended in 10 iL of ddH2O ready for sequencing. Assignment of
leading and lagging strand of replication for predicting mispairing events leading to










Figure 2.1. Strand Designation for Interpretation of Sequence Results.
dNTP Pool Extraction
HeLa and HCT 116 cell extracts used for the replication reactions were
analyzed for their endogenous dNTP contents. To isolate dNTP from the cell extract,
10 jil of ice cold 50% TCA was added to 90 jil of cold cell extract to make final
concentration of 5% TCA. The precipitate was immediately centrifuged at 4,000 rpm
in the fixed-angle Eppendorfmicrocentrifuge for 4 minutes then at 10,000 rpm for 5
minutes at 4°C. The supernatant fraction was neutralized with 1.5 volumes of 0.5 M62
tri-N-octylamine in Freon (Leedset al.,1985). After checking that the pH of the
upper aqueous phase was around 5.5, the aqueous phase was transferred into a clean
microfuge tube and dried in a Speed-Vac (Savant). The residue was redissolved in
100 t1 of water or dNTP pooi assay buffer (45 mM Tris-HCI, pH 8.3), and it was
ready for pool analysis.
dNTP pool assay was done as described previously (Leedset al.,1985).
Essentially, 5 j.il of each extracts was added to 45l of the reaction mixture to give
final concentrations of 45 mM Tris-HC1 pH 8.3; 4.5 mM MgCl2; 1 mM 13-
mercaptoethanol added just before use; 0.2 mg/mL bovine serum albumin (BSA); 8
.tg/ml of either poly-dAdT template for quantitating dATP and dTTP or poly-dIdC
template for dCTP and dGTP; 1 unit/mL of E. coli DNA polymerase I large fragment
(Klenow fragment); 10 mM dAMP to inhibit proofreading; 2 tM complementary
dNTP and 0.01 iCi/d of complementary [3H]dNTP. For dATP quantitation dTTP is
the complementary dNTP, for dTTP, dATP is the complementary dNTP, for dCTP,
dGTP is the complementary dNTP and for dGTP, dCTP is the complementary
dNTP. Standards of known amounts of each dNTPs were included in each assay. The
amount of dNTP in each unknown samples was determined through interpolation of
the standard curve generated for every assay. It is important to note that the use of
Klenow exonuclease fragment as DNA polymerase in place for Kienow has not
worked well for dCTP quantitation as the reactions seemed to be very slow to come
to completion. Also, diluting the extracts several-fold seemed to increase the
measured dNTP concentration in the extracts. To solve this problem the extracts
have been diluted four- to sixteen-fold until no further increase was seen in the
values of dNTP concentrations obtained from higher dilutions. The same dilution
factor was used for the measurement of all dNTP in the extracts.
Cell lines that were analyzed for dNTP concentrations used in the replication
reaction with normal human diploid fibroblast dNTP pools were IMR-90, obtained
from ATCC, and NDHF cells obtained from Dr. Janet Leeds (Isis Pharmaceuticals)63
in which the pool measurements were done by Linda Wheeler in Dr. C. K. Mathews'
laboratory.
RESULTS
EFFECTS OF dGTP BIAS ON MUTA TION FREQUENCY
Biologically biased dNTP concentrations can be predicted to have two effects
on DNA replication accuracy. First, an increase in mutation frequency opposite
template C in DNA can be expected since dGTP is the least abundant in
concentration compared to other dNTPs in competing for incorporation. Second, low
concentrations of dGTP, that is, below the Kd for correct dNTP binding, could delay
its incorporation opposite template C, which would favor exonuclease to act on a
mispair prior to template C, hence decreasing mutation frequency 5' to template C.
Previous experiments with M13mp2SV/opal7 DNA replicated using HeLa cell
extract and either equimolar or biologically biased dNTP concentrations (Zhang and
Mathews, 1995) were inconclusive. One reason was the use of HeLa cell extracts
with mismatch repair capability that could correct some mispairing errors therefore
preventing them from being scored as mutants. Another reason was that one possible
error, G-A transition within the opal codon, could not be scored because it yielded
an ochre codon which has the same phenotype as the opal codon when plated onE.
coli CSH5O. Therefore, the experiments were repeated with some modifications.
Mismatch repair-deficient cell line HCT 116 extracts were used as well as HeLa cell
extracts to examine the effect of mammalian mismatch repair complexes on the
observed mutation frequency.E.coli NRl 1089, instead of CSH5O as the a-
complementing E. coli, was used to score all possible revertants of the TGA codon
since it carries an ochre suppressor.64
As shown in Table 2.1, there is no increase in the mutation frequency
differences between equirnolar and biased replication reactions when done using
HCT 116 compared to HeLa cell extracts. This result agrees with Roberts and
Kunkel's (1993) suggestion that the amount of DNA used in the in vitro replication
reaction is probably sufficiently large to overwhelm the mismatch repair complexes
if they are active in the extract. Furthermore, no significant difference in mutation
frequencies (p = 0.28 1 Fisher's exact test) was observed between replication
reactions with equimolar and biased dNTP concentrations (data used for statistical
analysis are presented in Figure 2.2). However, the nature of the data collected
suggests that if a small difference were present between the two reaction conditions,
the difference would most likely be undetectable due to the large confidence interval
for the ratio of the two mutant frequencies (bias over equimolar).
The next question that was addressed was how much of a pool imbalance was
needed in order to see a detectable change in the mutation frequency. The dGTP
concentration was then systematically lowered while keeping other dNTPs at
biologically biased concentrations. In this experiment mismatch repair-deficient cell
line HCT 116 extracts were used to replicate M13mp2SV/opal7 DNA in reaction
mixtures containing biologically biased dNTPs with high or low dGTP
concentrations as shown in Figure 2.2. When dGTP concentration in the replication
reaction was systematically lowered, no meaningful increase in mutation frequency
was observed even when dGTP concentration was 6000-fold lower than dATP or
dTTP in the reaction mixture.
On the other hand, a I 00-fold increase in dGTP concentration over the
physiological value increased the mutation frequency more than five-fold as was
previously shown (Zhang and Mathews, 1995). Shown in Figure 2.2 also is the total
number of plaques (pfu) produced in the 25-tI replication reactions. It decreases
from high dGTP bias to the lowest dGTP bias (i.e., dGTP 10 nM, other dNTPs at
biologically biased concentrations). Although it is possible, especially in the lowest
dGTP bias reaction, that the replication complex dissociated from the template such65
that an appreciable amount of DNA template was not replicated to completion, and
hence the decease in the pfu observed; this is probably not the case in the equimolar
(all dNTPs at 100 tM) and the biologically biased dNTP reactions.
Table 2.1
Reversion Frequency of Opal Codon Measured with HeLa or HCT 116 Extracts
extract replication condition mutant/total mutant frac-
plagues counted tion x I
HeLa untreated 15/532,600 2.82
equimolar 21/485,350 4.33
biologically biased 27/681,700 3.96
HCT 116 untreated 9/2,048,250 0.44
equimolar 59/2.027,925 2.91
biologically biased 34/1,457,392 2.33
M13mp2SV/opal7 was replicated using HeLa or HCT 116 extracts as described in
materials and methods section. "Untreated" refers to mutations when the phagemid
template DNA was not replicated with extracts, but directly electroporated and
plated onto the plating E. coli. In the equimolar and biologically biased reactions, the
template DNA was cut withDpnIto completion after the reactions; therefore, blue
plaques that are scored from either eguimolar or biased reactions would most likely
arise from mispairs in the DNA synthesis during the replication reactions, and not
from template DNA.
It is possible that in the reactions with dGTP concentrations as low as 10 nM,















Figure 2.2. Effect of dGTP Bias on Mutation Frequency. M13mp2SV/opal7 was
replicated with HCT 116 extracts. All other dNTPs in the reaction mixture for the
100 tM dGTP data point were 100 M, whereas for all others, the reaction mixtures
consist of dATP 60 M, dTTP 60 M, dCTP 30 M and dGTP as indicated.
Mutation frequencies were averaged from two different experiments under similar
plating conditions. Total pfu (right axis) represents plaque-forming units per 25-j.i1
reaction mixture. Diamonds represent mutation frequency and triangles total pfu
values.
frequency. Measurement of [a-32P]dCTP incorporation showed that the replication
rate did decrease appreciably when dGTP concentration was 10 nM (Figure 2.3A).
However, there was almost no difference in the replication rates between replication
reactions with 10 mM or 1 mM dGTP when all the other dNTPs were held at
biologically biased concentrations, suggesting that the estimate of dGTP
concentrations in HeLa cells is not rate-limiting in the in vitro reaction.67
Figure 2.3. Analysis of Replication Reactions with Different dGTP
Concentrations. A. Replication rate; diamonds represent 10 nM dGTP; squares, 10
mM dGTP; triangles, 1 mM dGTP. B. Autoradiogram of the replication products.
Aliquots of each reaction mixture after 90 minutes of incubation digested withDpnI
(lanes 1, 3 and 5) orMboI(Ianes 2, 4 and 6) and electrophoresed in 1% 0.5x TBE
gel at 100 V for about 1 hour. Positions of RF I and RF II were determined in
separate analysis.69
Analysis of replication products withDpnIorMboIshowed in Figure 2.3B
confirmed that most of the reaction products are hemimethylated since the
replication product are resistant to both restriction endonucleases(Dpn Icuts
methylated DNA andMbo I cuts unmethylated DNA). This result suggests that
replication of the template DNA occurred once during the reaction.
EFFECTS OF dGTP OR dTTP BIAS ON "DIAL YSED" HELA CELL EXTRA CT
To better compare the data with previous studies, the replication reactions
were repeated with HeLa cell extracts under condition of low dGTP biases. The
HeLa cell extracts were also treated with Centri-sep spin columns to eliminate
almost all of the nucleotides present in the extracts; the extracts were termed
"dialyzed". The effect of extremely low dNTP biases on mutation frequency was
able to be evaluated using the dialyzed extract. Also instead of biologically biased
dNTP concentrations, 100 M of the other dNTP concentrations were used in the
reaction for a more comprehensive study of the experimental conditions. Finally,
dGTP biases were compared with dTTP biases, to ensure that the effect of dGTP
variations was not a specific effect of dGTP on the replication complex.
The Centri-sep column removed 99% of the dNTP present in the extract with
no detectable effect on the replication activity as measured by the[a-32P] dATP
incorporation assay. Residual dNTP concentrations in 25 p.L extract after Centri-sep
procedure were 6 nM for dATP, undetectable (< 1 nM) for dCTP, 0.5 nM for dGTP
and 4 nM for dTTP. These values were taken into account in the calculations of
dTTP or dGTP present in each reaction.
Similar effect of biased dGTP (i.e., low or high dGTP concentration, other
dNTPs at 100 tM as shown in Table 2.2) as biologically biased dGTP reactions (low
or high dGTP concentration, other dNTPs at biologically biased concentrations as
shown in Figure 2.2) on mutation frequency were observed. Again, in the reactions70
where dGTP concentration is varied at 1 or 100 tM, the mutation frequencies varied
only slightly. Mutation frequency increased about two-fold when dGTP
concentration was 1 mM. When dGTP concentration is very low in the reaction
(0.0015 i.tM), 66,000-fold lower than other dNTP concentrations, a four-fold increase
in mutation frequency was observed. However, at very low dNTP concentrations, the
replication complex could dissociate repeatedly from the template; therefore, the
mutation frequency observed is could reflect an inaccurate measure of processive
DNA replication fidelity.
The mutation frequencies from replication reactions with dTTP bias (Table
2.2) were very similar to the result for dGTP biases except probably at the lowest
concentrations. However, dTTP concentration lower than 4 nM (which is the
Table 2.2.
Effect of dGTP or dTTP Concentration Bias on Mutation Frequency in
Replication with "Dialysed" Extracts
dGTP/dTTP concentration mutant frequency x 1 0






The dGTP and dTTP concentrations were varied as shown, while other dNTPs were
held constant at 100 tM. dGTP and dTTP concentrations indicated were the sum of
added and residual dNTPs present in the "dialysed" HCT 116 extracts.71
concentration of dTTP present in "dialysed" HeLa cell extracts) in the reaction could
not be assayed. In the reaction with dTTP concentration of 5 nM, 20,000-fold lower
than other dNTPs in the reaction, the mutation frequency is increased less than 1.5-
fold compared to the mutation frequency of the equimolar dNTP reaction. Perrino
and Loeb (1988) did an in vitro replication reaction using purified calf thymus DNA
polymerase a, 4Xl74 am3 DNA substrate and low dTTP concentration biases. They
found that mutation rate increase was not linear with respect to the concentration
biases. However, low dTTP biases in their system increased the mutation frequency
significantly. One argument for the different result between the above experiment
and this study is in the ability of DNA replication complex of the extracts in thein
vitro replication reaction system to carry out accurate DNA replication that closely
resemblesin vivoreplication reaction (Li and Kelly, 1985) compared to replication
reaction carried out only by purified DNA polymerase a. However, another
important difference between the two experiments is that in Perrino and Loeb's
experiment the concentration of other dNTPs in the reaction was 1 mM, while in the
experiment conducted for this study the concentrations of other dNTPs are 100 M.
This difference in the level of other dNTPs in the reaction influences the observed
mutation frequency as can be shown subsequently in this study.
SPECTRA OF MUTATIONS AT THE TGA CODON IN REACTIONS WITH
BIOLOGICALLY BIASED dNTP AND SISTEMATICALLYHIGH OR LOW
dGTP
To understand the effect of dGTP underrepresentation on specific replication
errors, individual mutants were sequencd from the sets of replication reactions in
which biologically biased dNTP pools with either high or low dGTP concentrations
were used (mutants from Figure 2.2). As illustrated in Figure 2.4, nine possible






I I I I I I













revertants (GA ?\.GA(.jGAT(:A T1.A TG(.TGTTG(...
Figure 2.4. Substitution Pathways from Insertion Errors during Replication of
an Opal Codon. The resulting revertants from mispairing in lagging strand (first
row) or leading strand (second row) are shown directly beneath the mispairs (last
row).
revertants. None of the revertants sequenced were GGA, which is the result of either
T:dCTP mispair on the lagging or A:dGTP mispair in the leading strand during
replication (Figure 2.5). This could suggest that both mispairs were probably not
favourably formed or they were corrected very efficiently. A:dGTP mispair leading
to GGA revertant is predicted to be one of the most common mispairs in reaction
where dGTP is present at high concentration and template A is directly 5' to C
during replication (which is represented by "A" on Figure 2.5). Instead of GGA,
CGA was the most common revertant obtained in this set of reaction, and GGA was
totally absent from the mutation spectrum. It was noted before that A:dGTP
mismatch was rarely formed in the replication with human cell extract and
unmodified dNTPs (Thomas etal., 1991).
Some other notable results can be concluded from the available sequence
data. First, there seem to be different preferences for revertants that are formed in the
equimolar as opposed to biologically biased dNTP reactions. On the other hand,73
Figure 2.5. Sequence Analysis of Reversions from Opal Codon of the IacZa
Replicated with Biologically Biased dNTP Concentrations. The sequences
represented above are from revertants isolated from replication reactions depicted in
Figure 2.2. Panel A, C, D and E represent revertants isolated from replication
reaction with biologically biased dATP, dTTP and dCTP concentrations. dGTP
concentrations were: 1 mM (high, panel A), 10 tM (biologically biased, panel C),
0.3 tM (low, panel D) and 10 nM (lower, panel E). Panel B represents reactions with
equimolar dNTPs (100 tiM). Nine mutants were sequenced from high dGTP
reaction, 12 from equimolar, 11 from biologically biased and 10 each from low and


















































biologically bias, "low" (dGTP is 0.3 NM), and to some extent "lowest" (dGTP is
0.01 pM) biologically biased dNTP reactions shared similar revertant representations
(Figure 2.5) that are different from the equimolar dNTP reaction. As illustrated in
Figure 2.4, each of the revertants can be formed as the result of different mispairing
on either leading or lagging strand during replication. In the equimolar dNTP
reaction, it is difficult to distinguish whether a specific revertant arose from a mispair
in the lagging or leading strand replication. However, in the replication reaction with
biologically biased dNTP it is predicted that mispairs on template C and 5' to
template C on the leading strand would be more predominant since dGTP is lowest
in concentration. TTA, the most prevalent revertant in the biologically biased dNTP
reactions, is therefore most probably the result of C :dTTP mispair on the leading
strand. TTA is also one of the revertants represented in the equimolar dNTP reaction;
however, TCA is the more predominant revertant (Figure 2.5).
Second, from previous experiments using the forward mutation assay of the
M13 phagemid and equimolar dNTP concentrations (Roberts and Kunkel, 1988) it
was expected that C:dATP mispair would be formed more frequently then either
C:dCTP or C:dTTP. C:dATP mispair on the template strand of M13mp2SV/ochre7
would result in an ochre codon; therefore, E. coil NRI 1089, an ochre suppressor,
was used to be the a-complementing E. coli strain. However, as shown in Figure 2.5,
only two out of all the revertants sequenced was TAA. The preference of forming
other mispairs than C:dATP at this particular site could be due to the sequence
selectivity of the surrounding basepairs, which can affect the mispair formed at a
particular site in a DNA sequence.
In conclusion, from the available sequence data it can be stated that there is
significant difference (p = 0.02 8, Fischer's exact test) between the mispairs formed
opposite template C in replication reactions with equimolar versus biased dNTP
concentrations; although the amount of sequence data available is small. Predicting
possible important mispairs formed in vivo using equimolar dNTP replication76
reaction, therefore, might not be accurate if in fact biologically biased dNTP pool
supplies mammalian DNA replication in vivo.
Previously, two effects were predicted of low dGTP concentration on











Figure 2.6. Calculated Mutation Frequency within Opal Codon. The calculated
mutation frequencies plotted were estimated as proportion of specific mutant class
from the total mutants sequenced multiplied by the average mutation frequency for
the particular reactions. Data are from experiment represented in Figure 2.5. Grey
bars represent equimolar reaction mixture, open bars biologically biased reaction
mixture and black bars low dGTP reaction mixture.
mutation frequency 5' to template C. In Figure 2.6, the calculated mutation
frequency of revertants at the two different mutation sites of the opal codon: 5' to
template C and on template C, was compared. These calculated mutation frequencies
were derived from the proportion of sequenced mutations of specific sequences in a
particular reaction multiplied by the total mutation frequency of that reaction. The77
calculated mutation frequencies of the two positions on the TGA codon can be used
to evaluate the effect of underrepresentation of dGTP in each position. Aithugh the
sequence data were to small to draw conclusive results, it can be stated that the
mutation frequency 5' to template C between equimolar, bias, and low bias
replication reactions shows a tendency to decrease in that order suggesting the effect
of low dGTP in decreasing the mutation fequency.
To distinguish the possibility whether A:dCTP mispair in the leading strand,
which would generate CGA revertant for the biologically bias reactions, is either
proofread very efficiently when dGTP concentration is low or not preferentially
formed in biologically biased dNTP reaction, the DNA template was replicated using
HCT 116 extracts, biologically biased dNTP concentration, and either 0.5 mM or 1
mM dAMP to inhibit proofreading (Table 2.3).
Table 2.3
Effect of Inhibited Proofreading on Relication Error Frequency
extract [dAMPI mutant/total mutant fraction
(mM) plaques counted x I
(untreated) 9/2,048,250 0.15
HCT 116 0 34/1,457,392 2.33
0.5 30/157,067 19.1
1 39/143,600 27.2
The reactions were carried out with biologically biased dNTP concentrations in the
presence of dAMP as indicated.78
As expected, the mutation frequency increases considerably when dAMP was
added to the reaction to inhibit proofreading. In the reaction with 0.5 mM dAMP
eleven out of eleven revertants sequenced are AGA, which most likely resulted from
A:dATP mispair 5' to template C. Therefore, A:dCTP is most probably not
preferentially formed.
REPLICATION REACTION WITH TAA CODON
The sequence data thus far indicate that there is a tendency towards a
decrease in mutation frequency opposite template C when dGTP is low in
concentration. In order to examine the effect of biologically biased dNTP
concentration without the added effect of mismatches opposite template C, another
DNA construct, M13mp2SV/ochre7, was used which has an ochre codon in place of
TGA. Directly 5' to the ochre codon is template C, which is a silent mutation of the
original codon (C-TAA). This template was used to hopefully result in a significant
decrease in the mutation frequency of the reaction with biologically biased dNTP
Table 2.4
Reversion Frequencies of Ochre Codon in Reactions with Equimolar and
Biologically Biased dNTP Concentrations




biologically biased 6/267,440 2.24
In the reactions above, the construct M13mp2SV/ochre7 was replicated with HCT
116 extracts.79
concentration when compared to equimolar dNTP concentration. As presented in
Table 2.4, there does not seem to be any difference between mutation frequencies of
the two reactions. However, from nine possible revertants two would produce a stop
codon, which would be indistinguishable from the background. As previously
discussed, A:dCTP mispair is one of the major mispairs observed for equimolar
dNTP reactions at this codon. A:dCTP mispair on either first or second A template of
the TAA codon would produce a stop codon. Therefore, the mutation frequency of
TAA template replicated with equirnolar dNTP concentrations could be an
underrepresentation of the actual mutation frequency. In the biologically biased
dNTP reaction, instead of A:dCTP, A:dATP mispair constituted the predominant
mispair observed. Then it is probably unlikely that TGA or TAG is a major
contributor of revertants in the biologically biased reaction since both involved
mispairing of A:dCTP. This could be interpreted to mean that the observed mutation
frequency of M13mp2SV/ochre7 replicated with biologically biased dNTP
concentrations probably closely resembles the actual mutation frequency. Therefore,
although indirectly, replication with biologically biased dNTP concentration could
result in a lower mutation frequency than replication with equimolar dNTP
concentrations. However, more experimentation is still needed.
REPLICATION REACTION WITH "DIPL OlD FIBROBLAST" dNTP
CONCENTRATION
In general, untransformed mammalian cell lines have lower dNTP
concentrations compared to HeLa cell dNTP pools. Table 2.5 shows the calculated
the average of each of the dNTP pool concentrations of human diploid fibroblasts
measured from IMR9O, normal human diploid fibroblast and human fibroblast pool
data from other laboratories. By assuming that there is very little difference in the
proportion of nuclei to the whole cell volume of HeLa and human diploid fibroblast
cells, the concentration of nucleotides present in the human diploid fibroblast cells80
Table 2.5
Estimation of Nuclear dNTP Concentration in Human Diploid Fibroblast Cell
Lines
cells dNTP pools (pmole/million cells)
dATP dTTP dCTP dGTP
reference
Human fore- 24 47 12 5 Snyder, 1984
skin fibroblast
Normal embryonic 15 31 30 10 Collins and
lung fibroblast Oates, 1987
IMR9Odiploid 30 75 18 8 this study
fibroblast
Normal diploid 30 45 20 10 this study
fibroblast
Average 25 50 20 8
Approximate nuclear 15 15 10 3
concentration, pM
The average values were used to estimate nuclear concentration in jiM using data
and assumptions of nuclear to whole-cell volumes, and the distribution of dNTPs
between nuclear and whole-cell HeLa extracts as reported previously (Leeds et aL,
1985).
was calculated (Table 2.5). The effect of replication using the "diploid fibroblast"
dNTP pooi concentrations on mutation frequency was evaluated. The result shows
that mutation frequencies of reactions with diploid fibroblast dNTP concentrations
are very much lower than the reaction with 100 jiM equimolar dNTP concentration
for both constructs involving either a TGA or TAA codon (Table 2.6). The mutation
frequencies seen in the reaction with diploid fibroblast dNTP concentrations were81
very accurate, resembling the untreated mutation frequency in both cases. Also
shown is the rate of replication reaction with diploid fibroblast dNTP concentrations,
which was only slightly lower than the rate of the reaction with biologically biased
dNTP concentrations calculated from HeLa cell nuclei (Figure 2.7). These data
suggest the importance of tight regulation of dNTP pools in controlling DNA
replication fidelity without considerably compromising the efficiency of DNA
replication in cells.
Table 2.6
Error Frequencies of Replication Reaction with dNTP Concentrations
Estimated for Diploid Fibroblast Nuclei
codon replication condition mutant/total mutant fraction
plaques counted x 10'
TGA untreated 4/202,250 1.97
equimolar (100 tM) 23/570,000 4.03
diploid fibroblast 2 1/3,194,000 0.66
TAA untreated 3/629,600 0.48
equimolar (100 M) 30/1,065,334 2.81
diploid fibroblast 2/557,400 0.36
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Figure 2.7. Effect of dNTP Concentrations on Replication Rates in Vitro.
Incorporation of dNTP was monitored by [a-32P]dCTP. Black rectangles represent
reaction with HeLa cell dNTP concentrations, open diamonds diploid fibroblast
dNTP concentrations.
DISCUSSION
Deoxyribonucleotide concentration during DNA replication is an important
determinant of DNA polymerase fidelity (Kunkel, 1992). Asymmetric dNTP
concentration can increase the frequency of misincorporation due to the competition
of the four substrates to the active site. However, in order for a misincorporation to
become a mutation, the mismatch terminus has to be extended and not corrected by
the 3' -5' exonuclease proofreading activity. Extending mismatch termini requires a
high concentration of the next nucleotide; hence, overall nucleotide levels are also an
important determinant of DNA polymerase fidelity (Kunkel, 1988). Another factor
contributing to polymerase fidelity is the observation that some mismatches can be
extended more easily than others (Creighton et al., 1992), and there is also some
evidence of differential proofreading activity on different mismatches in vivo
(Meuth, 1989). The accumulation of revertants in the replication reaction therefore83
depended upon all of the above factors. In the in vitro replication reaction, other
factors that are actively present in extracts, such as different mismatch repair
complexes, could also contribute to the observed mutation frequency.
From the data presented here some notable conclusions can be drawn on the
effect of biologically biased dNTP concentrations on DNA replication accuracyin
vitro.First in thisin vitroreplication system, replication reaction using mismatch
repair deficient cell extracts does not seem to have an effect on the observed
mutation frequency. Second, replication reactions with biologically biased dNTP
pooi concentrations calculated from HeLa cell nuclei (Leedset al.,1985) were not
significantly more accurate when compared to the reaction with equimolar (100 tM
each) dNTPs. Sequence analysis of revertants shows that in the biological dNTP
reaction there can be preferences for forming certain revertants that are different
from reactions with equimolar dNTP concentration. Third, an effect that can be
inferred from the sequencing is that in the biologically biased dNTP, there is a
tendency for a decrease in mutation frequency 5' to template C when dGTP
concentration in the reactions were lowered while other dNTPs were kept at
biologically biased estimate. Also, next nucleotide concentration of 60 M (in the
case of biologically biased reaction) and 100 tM (in the case of biased dTTP and
dGTP reactions) is probably not enough to extend mispairs significantly without
correction since lowering the concentration of dGTP several thousand fold, which
should increase the probability of mispairs opposite template C, did not tend to
increase the mutation frequency opposite template C proportionally.
Biologically biased dNTP concentrations used in most of the experiment in
this study are calculated from dNTP poois of HeLa cell nuclei. Untransformed,
normal diploid cells in culture, such as human diploid fibroblast cells, have lower
whole-cell dNTP pool concentrations than HeLa's. By assuming that the proportions
of the nuclei compared to whole cell volume are similar in the two kinds of cell lines
in culture the approximate nuclear dNTP concentrations for fibroblast cells were
calculated and used for replication reactions. The mutation frequency was not84
significantly different from that of the background, which is even lower than seen
with the equimolar (100 1.tM) dNTP concentrations. Extension from a mismatch
terminus is probably very unfavorable at the low diploid fibroblast dNTP
concentrations thereby decreasing the overall mutation frequency without affecting
the replication rate, ensuring high efficiency of replication with high fidelity.
The notion that transformed cell lines with increased overall dNTP
concentrations have higher mutation frequency during replication compared to
normal dividing human cells with lower overall dNTP concentrations merits further
experimentation. Most cells found in human tissues are not rapidly dividing;
therefore, except for their mitochondrial dNTP pools, the dNTP pools are negligible.
However, it would be interesting to see whether the "abnormally" high dNTP pools
(higher than the rapidly dividing normal cell dNTP pools) that these cells seemed to
have after they are transformed to cancer cells accounts for the increase in mutation
frequency seen with most cancer cells.
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CHAPTER 3
DEOXYGUANOSJNE TRIPHOSPHATE LEVEL AND THE RATE OF DNA
ACCUMULATION DURING S-PHASE IN HELA CELLS
Stella A. Martomo and Christopher K. Mathews




Deoxyguanosine triphosphate (dGTP) concentrations in most mammalian
cells represent only 5 10% of the total whole-cell dNTP pools. This study
investigated whether dGTP, being the lowest in concentration in cells, becomes
limiting for the rate of DNA synthesis during S-phase in HeLa cells. Aphidicolin was
used to synchronize HeLa cells in early S-phase, which enabled the dNTP pools
during S-phase to be analyzed in these cells. Although it was found that in particular
dATP and dTTP pools were increased by about two-fold in the beginning of S-phase
in aphidicolin-treated HeLa cells, the rate of DNA accumulation did not seem to be
affected except in the beginning of S-phase. Analysis of dNTP concentrations at
hourly intervals during S-phase showed that there was no major change in the ratio
of all four dNTP pools through S-phase. Also, addition of aphidicolin during S-phase
in HeLa cells seemed to affect dNTP accumulation in early but not in late S-phase,
suggesting that dNTPs are probably regulated differently in early than in late 5-
phase. All four dNTP concentrations were lowest in the middle of S-phase, where the
approximate nuclear dGTP concentration was about 2jIM.DNA accumulation is
high at the end of S-phase and low in middle and early S-phase. However, there were
times in both early and middle S-phase which had a relatively slow DNA
accumulation rates. Addition of 8-aminoguanosine and 2'-deoxyguanosine to the cell
medium increased the whole-cell dGTP pool approximately two-fold. Hourly
examination of DNA accumulation during S-phase with addition of 8-
aminoguanosine and 2'-deoxyguanosine 30 minutes before each time point indicates
that there could be an increase in DNA accumulation rate in early S-phase when
compared to DNA accumulation rate in untreated FleLa cells. However, the possible
increase in the DNA accumulation rate did not correspond to the time at which dNTP
pool levels were lowest in S-phase. Therefore, more experimentation still needs to be
done to address the potential role of dGTP in S-phase replication rate.88
INTRODUCTION
The origin of isochores, regions in the mammalian chromosome of
compositionally homogeneous GC content (reviewed in Sabeuret al., 1993)has been
suggested as the result of slight differences in spontaneous mutation frequency in
regions of mammalian chromosomes that are replicated at different times during 5-
phase (Wolfeetal., 1989).Gu and Li(1994)proposed a model correlating mutation
rates with the incidence of GC-rich isochores based on the fluctuation of
deoxyribonucleotides (dNTPs) supply during S-phase. Early observations ofdNTP
levels in mammalian cell lines during S-phase showed an increase in concentrations
of all fourdNTPs(Adamset al., 1971,Skooget aL, 1973,Leedset al., 1985).In
Chinese Hamster Ovary (CHO) cells, Leedsetal. (1985)showed that there was a
very significant increase in whole cell and a smaller but still significant imbalanced
increase in nuclear dCTP concentration during S-phase compared to the other three
dNTPs. However, only a few time points were taken during S-phase, and the
increase in dCTP pool was explained as the result of the use of a subline of the CHO
cell line lacking dCMP deaminase. Decreased conversion of dCMP to dUMP in
these cells causes dCTP to accumulate. A closer examination of dNTP levels during
S-phase in cells withdNTPlevels more representative of the levels in the majority of
mammalian cell lines studied is needed to substantiate the previous observation.
Another question in relation todNTPlevels in S-phase of mammalian cells is
whether the concentrations ofdNTPspresent for DNA polymerases during S-phase
affect the rate of DNA replication. The level of dNTP measured in mammalian cells
was calculated to be enough only for a few minutes of DNA synthesis (Reichard,
1988).Moreover, dGTP in most mammalian cells is almost always under-
represented, contributing only5 - 10%of the totaldNTPpool levels in cells
(reviewed by Mathews and Ji,1992).During S-phase does the level of dGTP
concentration drop significantly to affect the rates of DNA synthesis? Previous study
on DNA replication rate of HeLa cells during S-phase showed that replication rates89
are different in early, middle or late S-phase (Collins, 1978, and Collinset aL,1980).
Studies involving DNA fiber radiography to reveal the rate of replication fork
extension also suggested that elongation of new DNA is faster towards the end of 5-
phase (Painter and Schaeffer, 1971, Housman and Huberman, 1975). Therefore,
there are data supporting changes of DNA replication rates during S-phase; however,
no direct indication exists to show that the level of dGTP in cells during S-phase can
modulate DNA replication rates.
In this report the effect of different synchronization drugs on dNTP pool
levels in cells was examined, the effect of aphidicolin in several cell lines available
compared, and the dNTP pool levels and the average DNA accumulation rate in
aphidicolin-synchronized HeLa cells were measured. The whole-cell dGTP pool
was increased by addition of 8-aminoguanosine and 2'-deoxyguanosine to the cell
medium, and the effect of increased dGTP pool on DNA accumulation rate during
S-phase was examined.
MATERIALS AND METHODS
CELL LINES AND REA GENTS
HeLa and HeLa S3 cell lines were obtained from American Type Culture
Collection (ATCC). The cells were maintained in DMEM/F-12 medium, high
glucose (Gibco BRL) supplemented with 10% fetal bovine serum (FBS). Normal
diploid human foreskin fibroblast untransformed cell line was obtained from Dr.
David Barnes. The fibroblast cells were maintained in DMEM low glucose medium
(Gibco BRL) supplemented in 10% FBS. IMR 90 diploid lung fibroblast cell line
was obtained from ATCC, and maintained in E-MEM medium supplemented with
10% FBS, 1.5 gIL sodium bicarbonate and 1 mM sodium pyruvate. Chinese Hamster90
Embryo Fibroblast (CHEF/i 8) cell line was obtained from Dr. Prem Reddy, and was
grown in DMEM high glucose medium containing 5% FBS and 4 mM L-glutamine.
Stock solution of aphidicolin was 10 mM in dimethyl sulfoxide (DMSO) and stored
at 4°C. Mimosine (Sigma) was made up as 100 mM stock solution in phosphate
buffered saline (PBS: 8 g NaC1, 0.2 g KC1, 1.44 g Na2HPO4, 0.24 gKH2PO4in 1 L
double-distilled H20 (ddH2O), prepared as lOx solution, autoclaved). The stock
solution for ciclopirox-olamine (Sigma) was made as 5 mM in PBS. Roscovitine
(Calbiochem) was made as 10 mM in DMSO and stored at 4°C. 8-aminoguanosine
and 2'-deoxyguanosine were made as 10 mM and 100 mM in DMSO respectively,
and guanine was made as 100 mM in DMSO.
CELL SYNCHRONIZATION
Synchronization with aphidicolin was done as described by Matherlyet al.
(1989) with some optimization. The doubling time of HeLa cells in culture was
about 24 hours. The time the cells spent in S-phase was typically one-third of the
duration of the cell cycle; therefore, for HeLa cells, S-phase should be about 8-10
hours. Gi phase would be the longest of the cells' phases. To synchronize the cell
population at G1/S border or early S-phase, aphidicolin at a final concentration of 3
M was added to log-phase growing cells (immediately or 24 hours after the cells
were trypsinized and regrown in a new plate), for the indicated times for the first
block. The medium was then aspirated, the cells washed with prewarmed PBS, and
new medium was added to the cell, which were then incubated for another 15 hours
(termed "release"). Aphidicolin was added to the medium, and the cells incubated for
another indicated period of time. Upon washing with prewarmed PBS and adding
new medium to the cells, the cells immediately begin synthesizing DNA, as
confirmed by flow cytometry analysis.91
Additions of various drugs to the HeLa cells were done immediately after the
cells were reseeded onto new plates. The drugs were added at concentrations noted
on previously published data on cell synchronization (mimosine, final concentration
of 100 tM; roscovitine, 10 .tM and ciclopirox-olamine, 15 jtM) and for either 6, 8 or
10 hours. For effect of aphidicolin on various cell lines, the drug was added to final
concentration of 3 jiM to the cells' medium for one or two hours before the dNTPs
were extracted and measured.
FLOW CYTOMETR YANALYSIS
At the indicated time points, cells were harvested by trypsinization, moved to
a 50-mL conical centrifuge tube and washed twice with ice-cold PBS.
Centrifugations were done at 1,500 rpm, for 2 minutes, at 4°C in a Beckman
swinging bucket table-top centrifuge. After the second wash, the pellet of cells was
resuspended in PBS left in the 50-mL conical tube after aspiration. 2 mL of ice-cold
70% ethanol-H20 (vlv) was then added dropwise while the cells were agitated with a
vortex mixer. The cell suspension is fixed and can be left in the refrigerator for up to
a week.
Immediately before flow cytometly analysis, the ethanol-fixed cells were
centrifuged at 1,500 rpm for 2 minutes using the same rotor, aspirated and
resuspended in 500 j.iL of 1 mg/mL RNaseA in phosphate buffer solution (50 mg
RNase A, 279 mg of Na2HPO47H20, 972 rng of NaH2PO4H20 in 50 mL of ddH2O,
filter sterilized). The cells were incubated at 37°C for 10 minutes to degrade the
RNA present in the cells. The cells were stained with propidium iodide (P1), which
intercalates in both DNA and RNA; therefore, digesting the RNA present in the
sample to completion was essential in obtaining high quality flow cytometry profile
of the cells' DNA content. After RNaseA digestion, 200 jil of 300 jig!ml P1 solution
in PBS was added to each cell suspension, and the cells were incubated for 2092
minutes at room temperature in the dark. Thereafter the experiment was done in the
dark. The cell suspension was filtered through a 40-micron mesh immediately before
flow cytometry analysis. The flow cytometry machine (Coulter EPICS XL, Beckman
Coulter, Inc., Miami, FL) is courtesy of Environmental Health Sciences Cell and
Tissue Analysis Core facility, Oregon State University.
It is a good idea to have an untreated log-phase growing sample of the cells to
be able to set a correct gating for cells to be analyzed. Sometimes changes in the
cells or materials (age of P1 solution for example) can change the fluorescent
intensity gating; therefore, a normal growing cell culture treated at the same time in
each experiment can provide controls for flow cytometry gating parameters.
dNTP POOL AND DNA ACCUMULATION RATE MEASUREMENTS
dNTP Pool Extraction
dNTP pooi extraction is done by a quick extraction method. At the indicated
time points, the medium from the cells growing in plates was quickly aspirated. The
cells were washed twice, as quickly as possible, with 2 mL of ice-cold Tris-buffered
saline (TBS), after which each plate was left standing on its side for 30 seconds to let
all the TBS drain; next the plates were aspirated. Immediately, 3 mL of ice-cold 60%
(v/v) methanol, containing 1% (vlv) toluene was added to each plate, the plate was
rocked a few times and put in 20°C for 1 hour with occasional rocking. After, the
suspension from each plate was distributed into 3 1 .5-mL Eppendorf tubes. Another
1 mL of 60% methanol, I % toluene solution was used to wash each plate, and it was
also distributed among the Eppendorf tubes. Then the methanol extracts were
centriftiged at 14,000 rpm in a fixed-angle Eppendorfmicrocentrifuge for 30 minutes
at 4°C. The supernatant fraction was put into a clean tube and taken into dryness with93
a Speed-Vac (Savant). The residue in each tube from one plate was pooled into one
tube by solubilizing them in a total volume of 150 L of ice-cold 5% trichioroacetic
acid (TCA). Immediately following the 5% TCA treatment, 1.5 volumes of 0.5 M tn-
N-octylamine in Freon solution was added to each tube on ice, and each tube was
vortexed at high speed for 90 seconds. They were then immediately centrifuged at
10,000 rpm in the same rotor at 4°C for 10 minutes. The aqueous phase was put into
a clean tube, and brought to dryness in the Speed-Vac. The residue from two or three
plates per time point was resuspended in 100 jiL of ddH2O or dNTP pool assay
buffer (45 mM Tnis-HC1, pH 8.3), and it was ready for dNTP pooi assay.
dNTP pool measurement is as described before in Chapter 2.
DNA Accumulation Rate
The rate of DNA accumulation at each time point during S-phase was
approximated by measuring the change in the peak of DNA intensity of the cells'
DNA content profile obtained from flow cytometiy from one time point to the next,
averaged over the difference in time between the two time points. The fluorescence
intensity is linearly correlated to the DNA content of the cells. The percent
synchrony at each time point was not accounted; therefore, the DNA accumulation
rate presented served as an approximation of the average DNA accumulation rate
over the indicated times in S-phase.
Treatment with guanine (final concentration 0.1 mM) or 2'-deoxyguanosine
plus 8-aminoguanosine (each to final concentration of 0.1 mM) was done every 30
minutes before the next time points to fix the cells for flow cytometry.94
RESULTS
EFFECT OF SYNCHRONIZING AGENTS ON CELL dNTP POOLS
To analyze dNTP pool modulations during S-phase, the cells needed to be
synchronized at the beginning of S-phase or at the GuS phase border without
affecting their dNTP pools. Most of the common GuS or early S-phase
synchronizing agents that were tried changed the dNTP pools of cells when
compared to the untreated controls, although it seemed that the effects of the drugs
vary in different cell lines used. However, the changes that were observed could not
be concluded to be not "normal" changes of dNTP pools in unperturbed cells at GuS
or S-phase since the dNTP pool levels of cells at the specific phases of the cell cycle
could not be evaluated without the addition of the synchronization drug. Some drugs
such as hydroxyurea are known to act directly to decrease the dNTP pools to keep
the cells in G 1 phase; therefore, the use of this drug for the synchronization
procedure was avoided. Effects of other drugs that can be used for GuS border
synchronization, namely, aphidicolin, mimosine and ciclopirox olamine (see Figure
3.1 for structures), on cells' dNTP pool levels were evaluated. The effect of another
drug, roscovitine [2-( 1 -ethyl-2-hydroxyethylamino)-6-benzylamino-9-
isopropylpurine] (Figure 3.1), which acts very specifically to inhibit cyclin-
dependent kinase cdk2 (Meijeret al.,1997), was also evaluated. This drug arrests
cells at G2/M, and cells accumulate at GuS border.
Aphidicolin is a drug that binds to DNA polymerases a,andE(reviewed in
Malkas, 1998), and can be used to synchronize cells in early S-phase (Pedrali-Noyet
al.,1980). As shown in Table 3.1, addition of 3 .tM aphidicolin to log-phase
growing HeLa cells for one hour increased the steady-state dATP, dTTP and dGTP
pools in these cells. Earlier reports on administration of aphidicolin in 3T3 and V79
cells showed similar increase in at least the dATP pool levels in these cells (Bianchi95
et al., 1992). Addition of aphidicolin to log-phase growing CHEF 18 and IMR 90
cells showed an increase in dATP, dTTP and dCTP levels with a similar increase in
dGTP level for CHEF 18 cells. On the other hand, administration of the drug to log-
phase growing human diploid fibroblast cells for one hour did not seem to change
the steady state dATP, dTTP or dCTP levels, but dGTP was lowered in these cells.
Since there are changes in the dNTP pool levels when most cell lines were
treated with aphidicolin, the effects of other drugs available to synchronize cells at
GuS border were evaluated. Roscovitine is not normally used for synchronization;
however, since it has a very specific inhibition for cdk2, the drug was administered
to freshly plated HeLa cells for either 6, 8 or 10 hours (Figure 3.2). As shown, after
10 hours exposure to the drug, all four dNTP pooi levels were reduced considerably.
Furthermore, after release even from 6 hours of roscovitine block, the cells exhibited





Figure 3.1. Structures of the Different Synchronization Drugs.
Mimosine can be used to synchronize cells in GuS border. Some reports
have suggested that mimosine arrests cells in late Gi (Lalande, 1990); others have96
reported that it arrests cells at origin of replication (Moscaet al.,1992) or after the
onset of S-phase (Hughes and Cook, 1996). It seems that mimosine acts to
synchronize cells in a complex way perhaps involving more than one mechanism,
one of which is through inhibition of ribonucleotide reductase (Gilbertetal.,1995).
In HeLa cells addition of mimosine to freshly seeded cells for 6, 8 or 10 hours
decreased all dNTP pool levels to different extents compared to the untreated cells
(Figure 3.2). Previous observation in Chinese Hamster Ovary C400 (CHO) cells
treated for 6 hours with mimosine also showed an effect on the cells' dNTP pools. In
Table 3.1
The Effect of Aphidico tin on Unsynchronized Cells
cell lines % of untreated cells
dATP dTTP dGTP dCTP
CHEF 18 154148123148




Aphidicolin (3 tM) was added for one hour to the medium of log-phase growing
HeLa, CHEF 18, IMR 90 and human diploid fibroblast cell lines. dNTP pools were
extracted and assayed as in Materials and Methods section.
these cells, some decreases were observed in dGTP and dATP pools, the dCTP in
these cells was not changed, and the dTTP poois increased considerably (Gilbertet
al.,1995). These effects on CHO cells were not completely in agreement with the
results that was observed in this report; however, the cells in this experiment were
treated with 0.1 mM instead of 0.4 mM mimosine as in the CHO study. The effects97
on CHO cells are very similar to the effect of hydroxyurea on cells' dNTP pool.
Hydroxyurea is known as an iron chelator, affecting the dNTP pools by inhibiting
the ribonucleotide reductase enzyme. Mimosine is thought also to affect
ribonucleotide reductase by chelating iron as does hydroxyurea (Kulp and Vuilliet,
1996). These results demonstrate that mimosine disturbs the dNTP pooi levels of the
cells during synchronization.
Another synchronizing agent, ciclopirox olamine was shown to reversibly
inhibit HL-60 promyeloid leukemia cells at GuS phase boundary (Hoffmanet al.,
1991). It was also shown as one of the synchronization drugs that did not disrupt cell
cycle integration, defined as cyclin A and B accumulations, when S-phase
progression was blocked (Urbanietal., 1995).In fact, Urbanietal.(1995) showed
that prolonged exposure (24-3 6 hours) to aphidicolin and mimosine resulted in
disruption of nucleic and cytoplasmic cell cycle progression in UcLa S3 cells.
However, addition of ciclopirox olamine to freshly plated HeLa cells for 6, 8 and 10
hours showed greater than 50% decrease in dATP and dTTP levels in the cells
compared to the untreated cells (Figure 3.2). dGTP and dCTP levels in the treated
cells, especially for 6-hour treatment, was not as greatly decreased.
Addition of aphidicolin to freshly plated HeLa cells for 8 and 10 hours did
not substantially change the dGTP and dCTP pools, although dATP and dTTP pools
increased as seen previously with the one-hour treatment of aphidicolin to HeLa
cells. Also, there was more accumulation, 1.5- up to 2-fold for dATP and dTTP,
when the cells were exposed to the drug for 10 hours (Figure 3.2). However, the cells
proceeded through S-phase with very good synchrony after release from a block as
short as 8 to 10 hours (Figure 3.3). The increase in the pools also did not change
greatly the ratio of one pooi to another, dTTP>dATP>dCTP>dGTP; therefore, we
decided to analyze HeLa cells dNTP pooi dynamics during S-phase using a short
aphidicolin block to synchronize the cells in early S-phase.98
Figure 3.2. The Effect of Various Synhronization Drugs on HeLa Cells' dNTP
Pools. The different synchronization drugs were added to freshly seeded HeLa cells'
medium for either 6, 8 or 10 hours, and dNTP pools from the cells were extracted
and assayed as described in the Materials and Methods section. dNTP pools are
expressed as percent of untreated cells. Open bars represent treatment for 6 hours,
grey bars treatment for 8 hours, and black bars treatment for 10 hours.The absence



















































































































HELA CELL SYNCHRONIZATION WITH APHIDICOLIN
HeLa cells synchronization with aphidicolin resulted in a very good degree of
synchrony throughout S-phase as shown in the DNA content profile of the cells
collected at the indicated time points throughout the cycle (Figure 3.3). Two
aphidicolin blocks were used to achieve high degree of synchrony as reported by
Matherlyet al.(1989). After first addition of aphidicolin to the cell culture medium
for as long as 20 hours the cells were washed with PBS, and new medium was added
to the cells, which were then incubated for another 15 hours. The second aphidicolin
treatment was done for varying times as indicated (Figure 3.4). The dNTP pool
levels in HeLa cells during the course of the treatment are shown in Figure 3.4. The
figure shows the pool levels at different times during release from the first block, and
the accumulation of mainly dATP in the prolonged second aphidicolin block. After
20 hours of first block with aphidicolin, the dNTP pool concentrations in the
synchronized cells were much higher than the concentrations in the unsynchronized
cells, and dATP level was higher than dTTP, which was normally the largest pool in
HeLa cells. High concentration of dATP would inhibit the activity of ribonucleotide
reductase in human cells. Therefore, it is reasonable that after such a long halt of
DNA synthesis after crossing the G 1/S border the cells would eventually suffer
inhibited dNTP production. High concentration of dATP has also been shown to aid
in the caspase 3 maturation in the caspase cascade which leads to one of the cells'
apoptotic pathway (Oliveret al.,1996, Leoniet al.,1998). Prolonged exposure to
aphidicolin (36 hours) has been shown to increase the degraded DNA peak
characteristic of cells that underwent apoptosis in the DNA content profile by flow
cytometry (Urbaniet al.,1995).
One aphidicolin block immediately after the cells were seeded onto a new
plate gave as good synchrony as the double aphidicolin block that was used earlier.
Closer comparison of dNTP pools taken at a few time points during S-phase from
cells that were treated with aphidicolin for 13 hoursversus20 hours showed that the101
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Figure 3.3. Cell Cycle Analysis of Aphidicolin-Treated HeLa Cells. 1-leLa cells
were synchronized with two aphidicolin blocks, and after release from the second
block most of the cells proceeded through S-phase with high degree of synchrony.
Y-axis indicates number of cells and x-axis fluorescent intensities that are
proportional to DNA contents of cells. First column of profiles shows DNA contents
of cells during aphidicolin synchronization, and next two columns of profiles shows
the cells' DNA contents during S-phase at the indicated times in hours (inserts).102
Figure 3.4. dNTP Pool Levels in HeLa Cells during the Course of Aphidicolin
Synchronization. Open bars represent dATP, grey dTTP, black dGTP and striped










































































































difference between the two sets of poois was mainly at the first time point, the zero
time point immediately after release from the block (Figure 3.5). Jackson (1995)
noted that in 'agarose-trapped' nuclei of HeLa cells, S-phase progression resumed
with the expected early, middle and late characteristic replication patterns after a







time (hours) in S-phase
Figure 3.5. Comparison of dNTP Levels in S-phase of HeLa Cells Synchronized
with Either 13 Hours or 20 Hours of Aphidicolin Block. dNTP pools were
extracted at the indicated time points and assayed. The top figure is dNTP levels in
S-phase after 13 hours aphidicolin block and the bottom figure is after 20 hours
aphidicolin block. Grey lined box denotes the main difference of the dNTP pool
levels between the two sets of experiments. Open bars represent dATP, grey bars
dTTP, black bars dGTP and striped bars dCTP. Error bars represent averages of the






















Figure 3.6. Comparison of DNA Accumulation Rates in HeLa Cells Treated
with 13 Hours versus 20 Hours Aphidicolin Block. A. DNA content profiles of
HeLa cells in S-phase after 13 hours aphidicolin block (left flow cytometry profiles)
and after 20 hours aphidicolin block (right profiles) were deduced to give DNA
accumulation rates in either 0 to 3 hours or 3 to 6 hours (time points are shown by
the inserts) in S-phase (the peak of DNA intensity as shown by black lines for hours
3 to 0 or 6 to 3 in S-phase were subtracted to give the relative DNA accumulation
rates). X-axis represents cell numbers and y-axis the fluorescent intensity. B.
Schematic diagram of the resulting relative accumulation rates. Black lines are for 13
hours' synchronization, and grey for 20 hours' synchronization.106
When the DNA content of the cells in S-phase from the two different sets of cells
were analyzed, there was no considerable difference between DNA accumulation
rates in those cells (Figure 3.6), although there was some difference between the
DNA accumulated in the first three hoursversusthe second three hours of S-phase in
both sets of cells. It was noted that dNTP pool levels of HeLa cells in S-phase after
either 13 hours or 20 hours' block were appreciably higher than the steady-state
dNTP pools of HeLa cells. However, previous studies have also shown that whole-
cell dNTP pools during S-phase increased by least two-fold compared to the poois at
other time in the cell cycle (Snyder, 1984, Nordenskjoldet cii.,1970, Leedset al.,
1985). Therefore, I estimated that data on HeLa cells' dNTP pools synchronized in
early S-phase using a 12-hour aphidicolin block would approximate the dNTP pool
levels in the S-phase of an untreated cell.
HELA CELL dNTP POOLS DURING S-PHASE
Previous observation of dNTP concentrations during S-phase that was done
in our laboratory by Leedset cii.(1985) showed an imbalanced increase of dCTP
during S-phase in the CHO cells that were used. The dNTP pooi levels in S-phase
need to be evaluated more closely (at more time points in S-phase), using a cell line
which has a more typical ratio of steady state dNTP pools. For this study, the dNTP
pool levels in S-phase of HeLa cells synchronized with aphidicolin for 12 hours were
analyzed.
After aphidicolin synchronization when aphidicolin was added back to the
medium after release from aphidicolin block, the cells ceased DNA synthesis. DNA
content profile showed that there is no accumulation of DNA between the drug
addition and the next time point, one hour later. When DNA synthesis was blocked
early in S-phase, dATP and dTTP pools increased about 150%, similar to the
increase observed for these two pools during aphidicolin synchronization (Figure107
3.7). dCTP pooi was increased by a smaller amount. However, aphidicolin block
early in S-phase restored the otherwise depleted dGTP pools, suggesting that dGTP
did not undergo the turnover mechanism when replication is blocked at this point. In
contrast to the effect of DNA replication block during early S-phase on the poois,
blocking replication at the middle of S-phase did not seem to result in a notable
accumulation of dATP, dGTP and dCTP pools in cells. There was a notable
accumulation of dTTP in late S-phase; however, the extent of accumulation was not
as great as when the cells were blocked in early S-phase. This result could suggest
different regulation mechanisms of dNTP production and turnover rates in early
compared to middle or late S-phase.
Closer examination of dNTP pool levels in S-phase showed a drop of all
dNTP pool concentrations in the middle of S-phase that was not seen when only
three or four time points were taken during S-phase (Figure 3.8A). dATP
concentration was lower than that of dTTP in the beginning of S-phase but towards
middle or late S-phase, dATP concentration was higher than dTTP; dATP became
the highest of all four dNTP. dGTP concentrations, although increased at the
beginning of S-phase, dropped lower than HeLa cells' steady state dGTP
concentration in the middle of S-phase.
Is the drop in dGTP pool significant enough to slow replication in the middle
of S-phase? It was previously noted that S-phase DNA replication in HeLa cells
consists of slow and fast replication rates, with slow phase in the middle of S-phase
(Collins, 1978, Collins et al., 1980), although other reports have also suggested that
the rate was slowest in early S-phase and fastest towards the end of S-phase (Painter
and Schaeffer, 1971, Housman and Huberman, 1975). When the DNA accumulation
rate versus time from the DNA content profile was examined, the rate of
accumulation did not seem to correspond well to the dNTP pooi levels at the
indicated time points (Figure 3.8B). The highest increase in DNA accumulation rate
seemed to occur at the late S-phase stage, and although lower DNA accumulation108
Figure 3.7. Effect of Inhibition of DNA Synthesis on dNTP Pool Levels of HeLa
Cells during S-Phase. dNTP pools accumulated when DNA synthesis was inhibited
in early S-phase. Only dTTP showed a slight accumulation of poois when DNA
synthesis was inhibited in middle or late S-phase. Black bars are dNTP levels during
continuous S-phase in HeLa cells, and grey bars are dNTP levels after aphidicolin
was added back to medium at the indicated time points (black arrowheads).C
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Figure 3.8. S-Phase dNTP Pools and DNA Accumulation Rate in HeLa Cells
Synchronized with 12 Hours Aphidicolin Block. A. All four dNTP pools showed a
decrease in the middle of S-phase. However, the decrease in the dGTP pools is
appreciable since at the lowest concentration it can potentially affect the DNA
replication rate. dATP is represented by solid black line, dTTP solid grey line, dCTP
grey dotted line, and dGTP black dotted line. Insert represents the steady state HeLa
cells' dNTP pool level. Open bar is dATP, grey bar dTTP, black bar dGTP and
striped bar is dCTP levels. B. The average of DNA accumulation rate corresponds to
the time points when dNTP pooi levels in cells were measured. Black open bars
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rates were observed in early and middle stages of S-phase, they did not seem to
correspond to the low dNTP pooi levels (Figure 3.8). When the dNTP pooi levels
were averaged as early (0-3 hours), middle (3-6 hours) and late (6-8 hours) after
onset of S-phase, and compared with the corresponding average DNA accumulation
rates for those times, there seems to be a better correlation between the two
parameters (Figure 3.9A and B). However, these averaged values were not detailed
enough to give the specific time points in S-phase where dGTP might be limiting.
Therefore, it still cannot be concluded that the drop in the dGTP pool level in the
middle of S-phase correlates with slower rate of DNA accumulation in the middle of
S-phase. It seems consistent also to note that the patterns of DNA accumulation were
not just linear with slow DNA accumulation in early S-phase and highest DNA
accumulation in very late S-phase, although the average DNA accumulation rates for
0-3, 3-6 and 6-8 hours of S-phase seem to show this pattern (Figure 3.9B). There was
a slow DNA accumulation rate phase in middle or middle-late S-phase before the
high DNA accumulation rate in late S-phase in each experiment. Can an increase in
dGTP pool level inside the cell increase the DNA accumulation rates when they are
relatively slow,i.e.,in early and middle-late S-phase (Figure 3.8B grey open bars, at
hours 2 and 7 after the onset of S-phase)?
To answer the above question, the whole-cell dGTP pooi during S-phase in
HeLa cells needs to be increased. Addition of 2'-deoxyguanosine together with 8-
aminoguanosine or guanine to the cell culture media has been reported to increase
dGTP pooi level in cells (Areccoetal.,1988). Shown in Figure 3.10 is the result of
addition of either 2' -deoxyguanosine and 8-aminoguanosine (a nucleoside
phosphorylase inhibitor) or guanine to HeLa cell medium for 30 or 60 minutes
before dNTP pool extraction. Addition of 2'-deoxyguanosine together with 8-
aminoguanosine did increase the whole-cell dGTP pooi by about two-fold. However,
it also decreases the dCTP pool by more than half and dATP and dTTP pool by
about 30-40%. The dNTP pools of HeLa cells after treatment with 2'-


















Figure 3.9. Average dNTP Pool Levels and DNA Accumulation Rates for 0-3,3-
6 and 6-8 Hours after S-Phase. A. The dNTP pooi levels from Figure3.8Aare
plotted to give an average at early, middle and late S-phase. Grey bars represent
dGTP, striped bars dCTP, white bars dATP and black bars dTTP. B. Relative DNA
accumulation rates from Figure3.8Bare averaged and plotted. Error bars represent














Figure 3.10. The Effect of Addition of 2'-Deoxyguanosine plus 8-
Aminoguanosine and Guanine to the Whole-Cell dNTP Pools of HeLa Cells. The
different drugs were added to the log-phase growing HeLa cells for the indicated
amount of time (30 refers to 30 minutes incubation and 60 is 60 minutes incubation),
and dNTP pools were extracted and assayed from treated and untreated HeLa cells.
Error bars represent average values of two experiments.
Table 3.2
dNTP Pools of HeLa Cells Treated with 2'-Deoxyguanosine and 8-
Aminoguanosine
HeLa cells treatment pmole/million cells
dCTP dGTP dTTP dATP
none 161 26 145 101
2' -deoxyguanosine +
8-aminoguanosine, 30 mm 61 67 83 67116
normal growing 1-leLa cells in culture (personal observation); however, the reason
for the high dCTP level that was observed from time to time was not clear.
Next, DNA accumulation rates of HeLa cells treated with 2'-deoxyguanosine
and 8-aminoguanosine for 30 minutes before each time point were analyzed and
compared with the untreated controls. As shown in Figure 3.11, from hour 3 to 6 in
S-phase and also very-late in S-phase (hour 8), there did not seem to be differences
in DNA accumulation rates between untreated HeLa cells and 2'-deoxyguanosine
plus 8-aminoguanosine-treated HeLa cells. When the rates of DNA accumulation
were slow, such as at hour 2 and 7 of S-phase (Figure 3.1 1), there seemed to be a
possibility that an increase in dGTP level in cells from 2'-deoxyguanosine plus 8-
aminoguanosine treatment could increase the DNA accumulation rates. However
when the t -test with null hypotheses stating there were no differences between the
two means of DNA accumulation rates on both hour 2 and 7 of S-phase was
performed on the data shown in Figure 3.11, the p values were large enough so that
the null hypotheses could not be rejected at 95% significance level (O.l<p<O.O5 for
the difference in the means at hour 2 of S-phase, and O.3<p<O.25 for the difference in
the means at hour 7 of S-phase). The data do show that there were large uncertainties
for the differences in DNA accumulation rates, which could mask smaller
differences between the two sets of data. A repeat experiment with a higher degree of
freedom (three replicates for each time points, for example) or higher degree of
HeLa cells synchrony could potentially gave a cleaner data where relatively small
differences between the means could be statistically significant.
DISCUSSION
Analysis of dNTP pools during S-phase in HeLa cells showed that there was
no considerable change in the ratio of the four dNTPs throughout S-phase as seen in117
CHO cells. This analysis was based on HeLa cells synchronized with one 12-hour
aphidicolin block.
Analysis of the effect of aphidicolin on HeLa cells' dNTP pools showed that
dATP and dTTP pools did accumulate to more than 200% upon prolonged exposure
to aphidicolin (up to 24 hours). However, it has been shown previously that dNTP
pools during S-phase would be higher than in other phases of the cell cycle. The
levels of enzymes of dNTP synthesis such as ribonucleotide reductase are known to
be up-regulated in late GI phase. Moreover, dNTP pool levels during S-phase in
cells synchronized with either 13- or 20-hour aphidicolin block showed only an
initial elevation in the cells synchronized with 20-hour aphidicolin block. The levels
of dNTP pools during the remainder of S-phase in cells synchronized with 20-hour
aphidicolin block were similar to those synchronized with 13-hour aphidicolin block.
The DNA content profiles at 0, 3 and 6 hours time points for both sets of cells also
indicated that there were no differences in DNA accumulation rates between the cells
in the two synchonization procedures.
Addition of aphidicolin back to the medium during S-phase suggested that
regulation of dNTP levels by their production and turnover rate might not be similar
in all the phases of S-phase.
The levels of all of the dNTP pools seem to show a decrease sometime in the
middle of S-phase in HeLa cells. Very low dGTP concentration in the middle of 5-
phase was also observed. DNA content profiles of the cells at each time point in 5-
phase can be deduced to give an average DNA accumulation rate at specific time
points during S-phase. However, the DNA accumulation rates did not correspond
well with the dGTP levels. A repeat experiment approximating nuclear dNTP levels
in parallel to DNA accumulation rates during S-phase is needed to ascertain the
relation between dNTP levels and replication rates.
Despite the lack of correlation between the dGTP pool levels and the DNA
accumulation rates during S-phase presented in this study, it is interesting to note
that when the dGTP levels in HeLa cells were increased, and the DNA accumulation118
rates were measured, there were tendencies to suggest that the increase in dGTP
level, even when other dNTP levels were decreased, increased the DNA
accumulation rates at times in S-phase where DNA accumulation rates had been
slow in the untreated HeLa cells. Recently, Malinsky et al. (2001) has shown some
direct evidence of the relationship between dNTP levels in cells and replication rates.
They concluded that addition of exogenous dNTP increased the replication fork rates
in early stage of S-phase but not in the late stage of S-phase. However, they
synchronized HeLa cells in late Gi using thymidine block which is known to
decrease dCTP poois in cells. Therefore, in this study the effect of the
synchronization procedure on dNTP pools might have obscured the result that was
obtained. In contrast to Malinsky et al. (2001), the result presented in this study
could suggests that an increase in dGTP alone, and not in other dNTP levels, could
possibly increase the slow DNA accumulation rates. Although more experiments are
needed, this result could indicate the first evidence of the potential role of dGTP in
S-phase DNA replication rates in mammalian cells.
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CHAPTER 4
INDICATION OF SPONTANEOUS MUTATION RATE VARIATION DURING
MAMMALIAN CELL CYCLE
Stella A. Martomo and Christopher K. Mathews




A gfk gene carrying an amber mutation in amino acid position 39 (gfp-amb)
was inserted in different regions of HeLa cells' chromosomes that are replicated
either early, middle or late in the S-phase. Each HeLa cell clone was grown to reach
high enough population number to generate spontaneous mutation in one generation,
and then the mutant cells that had arisen,i.e.,cells displaying green fluorescent
phenotype, were sorted out from the population to eliminate the background mutants
in each clone. Two clones were designated middle-replicating and late-replicating
gfp-amb through both fluorescentin situhybridization and a quantitative PCR
method. The middle-replicating gfp-amb HeLa clone always accumulated more
mutants than the late-replicating clone after four days in culture. The spontaneous
mutation rate of the late-replicating clone was found to be at least two-fold higher
than the middle-replicating clone. This finding corresponds with dNTP level
modulation during S-phase in HeLa cells; dNTP levels are lower in middle S-phase.
Previous experiment usingin vitroreplication reactions showed that replication with
lower dNTP levels resulted in higher replication fidelity. These data are consistent
with the hypothesis that spontaneous mutation rates vary within the S-phase, and that
replication rate and dNTP level changes may be responsible for this variation.
INTRODUCTION
Differences in spontaneous mutation rate of early and late replicating genes
were first proposed as an explanation for the origin of isochores (Gu and Li, 1994),
i.e.,regions in mammalian chromosomes that have compositionally homogeneous
GC contents (reviewed in Sabeur ci al., 1993). Gu and Li (1994) proposed a kinetic
model in which changes in deoxyribonucleoside triphosphate (dNTP) concentrations
thoughout S-phase in mammalian cells as shown for Chinese Hamster Ovary (CHO)123
cells (Leedset al.,1985) would lead to different mutational biases at different
regions of the chromosomes. The mutational bias could explain the existence of
isochores if each isochore region were replicated at a specific time during S-phase.
However, replication of a specific isochore was not always exclusively either early
or late in S-phase. Eyre-Walker (1992) noted that some GC-richand -poor isochores
were replicated both early and late in the cell cycle. Moreover,thein vitroDNA
replication experiments showed that the fidelity of replication did not change
significantly with changes in relative dNTP pooi concentrations supplied for
replication (Chapter 2).
The in vitro DNA replication experiments suggested that higher
concentrations of each dNTP, even without any changes in the ratio of each dNTP,
affected DNA replication fidelity more than a deficiency of one dNTP during
replication (Chapter 2). It is interesting that in aphidicolin-synchronized HeLa cells,
the concentrations of all four dNTP poois during S-phase seemed to vary temporally
(Chapter 3). However, the relationship between measured dNTP pooi and
"replication active" poois, the dNTP pool that is seen by DNA polymerases in the
different replication foci during DNA relication in mammalian cells is poorly
understood (reviewed in Mathews and Ji, 1992). Nonetheless perturbations of dNTP
pools have been documented to produce a range of genetic effects associated with
inaccurate DNA replication and repair (reviewed in Kunz and Kohalmi, 1991).
Temporal differences in DNA replication rates from mammalian cells in
culture have also been observed (Collinset al.,1980). In HeLa S3 cells, there
seemed to be three phases of DNA accumulation during S-phase:i.e.,early fast
phase, slower middle phase and faster late phase (Collins, 1978). Our observation
showed that HeLa cell dNTP poois varies during S-phase. Moreover, a recent report
has indicated that addition of exogenous dNTP could accelerate the speed of
replication fork movement in early S-phase in HeLa cells (Malinsky,et al.,2001).
This observation directly relates dNTP concentrations during S-phase and DNA
replication rate.124
The use of green fluorescent protein (GFP) to evaluate spontaneous mutation
rate as described by Bachl et al., (1999) have been adapted to the study reported
here. GFP is chosen as the reporter for mutation in cells because cells that display
green fluorescent phenotype can be either sorted-out from the population or
collected; hence, the starting populations for spontaneous mutation rate
measurements are free from background mutant cells. Different number of mutant
cells that could arise during growth can lead to very significant differences of
calculated mutation rates between replicate cultures when they are not eliminated.
The spontaneous mutation rates of GFP-transfected HeLa cell clones that
have thegfpgene inserted in temporally different locations in the chromosomes: i.e.,
early, middle or late in S-phase were compared to examine whether there is a
measurable difference in spontaneous mutation rates between stretches of DNA
replicated early and late in S-phase in mammalian cells.
MATERIALS AND METHODS
CONSTRUCTION OF PLASMID ENCODING gfp-amber GENE
Plasmid pEGFP-C1 encoding the green fluorescent protein (GFP) with
mutations from Phe64 to Leu and Ser65 to Thr as well as silent mutations to use the
human preferred coding sequences was obtained from Clontech Laboratories. Site
directed mutagenesis by PCR was used to obtain pEGFPamb-Cl. Primers: 1 (GFP-
AM1), GCTACC GGTCGC CAC; 2 (GFP-AM2), GCTCGA GATCTGAGT
CC; 3 (GFP-AM3),5GATGCCACC TAG GGCAAG C; and 4 (GFP-AM4), 5GTC
AGC TTG CCC TAG GTG G were used as diagrammed to yield a tyrosine to amber
mutation at codon 39 of the GFP. Mutagenesis by four-primer PCR was done as
described in (Ho et al., 1989).125
5,
1;- 5'
Primers 1 with 4 and 2 with 3 were used with the pEGFP-C1 template separately to
amplify two different segments of the gene and introduce the mutated DNA codon
into the fragments. Next, the two amplified segments were usedas template in a PCR
reaction, and primers I and 2 were used to amplify the mutated gene. The PCR
program used was as follows: first cycle melting temperature was at
950C for 5
minutes, annealing at 50° C for 1 minute and extension at 72° C for 1 minute; the
subsequent 20 cycles melting temperature was at 95° C for 1 minute, annealing at 50°
C for 1 minute and extension at 72° C for 1 minute; the last cycle melting
temperature was at 95° C for 1 minute, annealing at500 C for 1 minute and extension
at 72° C for 5 minutes. The resultinggfp-arnbgene was selected as having a new
AvrII (New England Biolabs) restriction site in the gene. Plasmid pEGFPamb-C1
was constructed by replacing the gfj, gene cassette with the gfp-amb gene cassette.
After transformation into E. coil XL-1 Blue, pEGFPamb-Cl DNA isolated from
three different clones that tested positive for the presence of the new restriction site
in the plasmid was sequenced to confirm the presence of thc mutated codon and the
absence of any other mutation. Sequencing was done in the Center for Gene
Research and Biotechnology, Oregon State University, Corvallis, OR.
TRANSFECTION AND SELECTION OF HELA CLONES CONTAINING g/-
amb GENE
Electroporation was chosen as the method for introducing pEGFPamb-C 1
DNA into the HeLa cells. Stable transfection using electroporation, as reported,
usually resulted in incorporation of one copy or more rarely two Or three copies of
the DNA per cell (Potter, 1996). As noted, stable transfection with other methods126
such as lipofectin (Life Technologies), or calcium chloride resulted in tandem
incorporation of the DNA into a site in the host chromosome. Usually tandem
incorporation could result in up to 40 copies of the gene of interest per cell. For our
study, it is important to have just one copy of thegfp-ambgene per cell in each clone
for valid comparison of spontaneous mutation rate between the clones. Therefore,
electroporation was chosen as the transfection method.
Electroporation done at 250 V using a BTI electroporator yielded an optimal
result in the proportion of cells that took up the DNA versus the cells that died
during the process. Before electroporation, the cells were trypsinized, washed two
times with ice-cold sterile phosphate-buffered saline (PBS: 8 g NaCI, 0.2 g KC1, 1.44
g Na2HPO4, 0.24 gKH2PO4in 1 L double-distilled H20 (ddH2O), prepared as lOx
solution) and resuspended at a concentration of 1 0 cells/mi for stable transfection
and 10 x 1cells/mi for transient transfection. Linearized DNA was used for stable
transfection and circular plasmid DNA was used for transient transfection.
pEGFPamh-C1 was linearized with restriction enzymeDralil(New England
Biolabs). Linearizing the plasmid with this enzyme was found to give a higher
proportion of stable transfectants that carry the neomycin gene for drug selection as
well as the completegfp-ambgene. Ten tg of linearized DNA per 100 p.l of cell
suspension was used for stable transfection, while 25 ig of plasmid per 100l of cell
suspension was used for transient transfection.
The HeLa cells were maintained in 1:1 DMEM/F- 12 medium (Gibco BRL)
supplemented with 10% fetal bovine serum (FBS). Geneticin, G418 (Roche
Molecular Biochemicals) was used as the selection for the transfected cells 700
.tg/mL G4 18 in the medium was found to prevent untransfected HeLa cell growth;
therefore, this concentration of G4 18 was used in the media for selection of clones
and also for maintaining each clone in culture.
For stable transfection, the electroporated cells were plated at limiting
dilution in 24-well plates. The content of each well was calculated from previous
experiment to yield about 2-4 stable clones. Each clone was trypsinized inside a127
cloning ring and was replated and grown until they reached a population size big
enough (106 cells) for DNA extraction followed by PCR screening. For transient
transfection, the electroporated cells were plated onto 2 100-mm plates and grown
for 48 hours without any selection. The cells then were harvested and ready for
experiments.
PCR primers used for screening were: GFP-1A,5' GCA GAG CTG GTT TAG
TGA ACC G andGFP-2A,5CGT CGA CTG CAG AAT TCG AAG C that would
amplify a completegfp-ambgene only out of total cellular DNA under PCR
conditions used. The PCR program was as before except that the annealing steps
were done at 68° C. These primers did not yield any PCR amplification when used in
the reaction with DNA extracted from untransfected HeLa cells. Total DNA template
of at least 0.5 tg per 100 p.L reaction and 25 cycles were needed in order to see any
PCR amplification.
SOUTHERN BLOTTING
Eighty tg of isolated genomic DNA each was used per clone to detect the
presence of thegfp-ambgene. The DNA was divided into four restriction digestion
reactions, 20 i.g of DNA each, and it was digested with 5 X excess of enzyme unit
(5U/jg of DNA) to ensure complete digestion. Afterwards, the reaction mixtures
were extracted with phenol-chloroform once and precipitated with isopropanol and 3
M NH4Ac. The DNA was collected through centrifugation, pooled together in 40 tL
of TE and loaded onto the prepared 0.5 X TBE-agarose gel with ethidium bromide
that had been casted to have wide wells to accommodate the volume of the sample.
The gel was run in 0.5 X TBE buffer at 20 V overnight. The gel was then
depurinated by immersing in 0.25 M HC1 for 10 minutes with shaking. Immediately
afterward the gel was rinsed in ddH2O twice. Before Southern transfer, the gel was
denatured in 0.5 M NaOH, 1.5 M NaCl for 30 60 minutes at room temperature with128
shaking and was neutralized in 1.0 M Tris-HC1 (pH 8.0), 1.5 M NaC1 for another 30-
60 minutes at room temperature with shaking. The DNA was blotted from the gel by
capillary transfer to a positively charged membrane (Magnacharge, Micron
Separations Inc.) using 10 X SSC (made as 20 X SSC stock, 3 M NaC1, 300 mM Na
Citrate pH. 7.0) buffer overnight.
The membrane was washed in 5 X SSC buffer for 1 minute at room
temperature and air-dried. It was then UV crosslinked to fix the DNA to the
membrane. The membrane was then prehybridized in 50 mL of 5 X SSC, 2%
blocking reagent for nucleic acid hybridization from the Genius System (Boehringer
Mannheim), 0.1 N-lauroylsarcosine, 0.02% sodium dodecyl sulfate (SDS) and 50%
deionized formamide (50% deionized formamide, 3 X SSC, 10 mM EDTA (pH. 7.2),
0.06 M sodium phosphate buffer, 3 X Denhardt's solution, 0.2% SDS has worked
well also) at370C for 3 hours. Afterward, the probe mixture was added to the
solution, and the incubation was allowed to proceed for another 20 hours.
The probe was made with random oligonucleotide priming method, using
heat denaturedgfpgene as the template, [a-32P]dATP and Kienow fragment, in 20
pL reaction mixture incubated at 37° C for 4-6 hours. The reaction mixtures were
diluted to 100 mL with TE buffer, and it was processed through a desalting column
(Centri-Sep, Princeton Separations) to remove all the free nucleotides. Five tL of the
reaction was counted (Cerenkov count), and a calculated amount of at least 1 x 1
cpmlmL was used in the hybridization reaction. The calculated amount of probe and
50-100 pL of 10 mg/mL carrier DNA in a total volume of 400 tL was added to 50
pL of probe denaturing solution (1.2 M NaOH, 12 mM EDTA). The mixture was
mixed, centrifuged to bring the solution to the bottom of the tube, placed in a 65° C
water bath for 5 minutes and immediately put into ice before adding it to the
prehybridization solution.
The membrane was washed in a series of large volume washes. Immediately
after hybridization, the membrane was washed quickly with room temperature 0.1 X
SSC, 0.2% SDS twice in the hybridization dish. It was washed twice more in two129
large glass trays with about 200 mL each of the same solution. Then the membrane
was incubated twice in a large tray with rocking with approximately 400 mL of the
same solution for 1 hour each at370C with two washes in between. The last wash
was done with 5 mM EDTA (pH 7.2), 0.2% SDS for another hour at370C. The
membrane was then rinsed with room temperature 0.1 X SSC, air-dried and placed
on the phosphoimager screen between Saran wrap layers.
DETERMINATION OF REPLICATION TIMING USING FL UORESCENCE IN
SITU HYBRIDIZATION
Determination of replication timing of single copy genes with fluorescence in
situhybridization (FISH) was according to the method of Seligetal.(1992) and
Ausubelet al.(1989) with some modification. Briefly, the cells were grown for 20
hours on sterile glass slides fitted with detachable media chambers. The experiment
was started by washing the cells attached to the slides in ice-cold PBS twice. After,
4% paraformaldehyde (PFA) fixative (prepare immediately before use by heating the
4% PFA solution in 2/3 of the ddH2O volume needed to 60° C and adding 1 drop of
2 N NaOH; after the solution is almost clear, add concentrated PBS enough to make
1 X and adjust pH to 7.2 with concentrated HCI; filter sterilize; cool to room
temperature) was added to cover the cells which were then incubated in the solution
for 20 minutes at room temperature. After incubation, the fixative was aspirated, 3 X
PBS was added to each slide chamber, which was then incubated for 2 minutes to
stop the fixation. The slides were washed with 1 X PBS twice for 2 minutes each.
After the PBS washes, the detachable chambers were removed, and each slide was
dehydrated through a series of 5-minutes incubation in 50%, 70%, 95% and 100%
ethanol which were done in 150-mm tissue culture dishes. The slides were then air-
dried completely and transferred to slide boxes containing desiccant to be stored for
at least overnight at 80° C.130
The next day the slides were prewarmed to room temperature from 80° C
before they were rehydrated through a series of 2-minutes 100%, 95%, 70% and 50%
ethanol incubations. Next, the slides were denatured in 0.2 M HC1 for 20 minutes at
room temperature and for 15 minutes at 70° C in 70% deionized formamide, 2 X
SSC. Next, the slides were rinsed in 1 X PBS for 2 minutes, fixed with freshly
prepared 4% PFA fixative for 5 minutes at room temperature, rinsed again with 3 X
PBS to stop the fixation and washed twice, 30 seconds each in 1 X PBS. The slides
were dehydrated through a series of ethanol washes again, 2 minutes each, first in
50%, then 70%, 95%, 100% and another 100% ethanol. After they were completely
air-dried at room temperature, the slides were put in a box with desiccator and left at
80° C overnight.
The probe mixture was digoxigenin-labelled DNA that was made using the
Genius kit (Boehringer Mannheim) according to the manufacturer's instruction.
Briefly, DNA template was made fromBglIIandBshTI(MBI Fermentas) double
digest of pEGFP-C1 that cut thegfpgene cassette from the plasmid. The digest was
analyzed in an agarose gel, and thegfpgene band of interest was cut from the gel
and purified with a gel extraction kit (BioRad) according to manufacturer's
instruction. The yield was quantitated using UV absorbance at 260 nm, and the DNA
was used as template in the labelling reaction. The labelling reaction was done using
20 ng of denatured template DNA. The template was denatured by incubating an
Eppendorfmicrocentrifuge tube with template DNA inside in a boiling water bath
for 10 minutes, then the tube was immediately put into liquid nitrogen to cool as fast
as possible. The labelling reaction was done as suggested by the Genius kit
instruction with the denatured template DNA, random hexanucleotide primers
(Promega), dNTP mixtures with digoxigenin-labelled dUTP (Genius kit vial #6) and
DNA polymerase I (Klenow fragment) (USB) in 20-pJ total reaction mixture at 37° C
overnight. Estimation of yield was done using alkaline phosphatase-conjugated anti-
digoxigenin antibody (Roche Molecular Biochemicals), and usually about 50 ng/pJ
of digoxigenin-labelled DNA was obtained.131
For fluorescencein situhybridization, the probe and the non-specific salmon
sperm DNA need to be of 250 base pairs or less in length (Selig, 1992). The reaction
mixture (50 jiL) for each slide containing 10 jtg of sonicated salmon sperm DNA
(Pharmacia) was digested with DNAse I (0.5 mgl/ml) in React4 buffer (Promega) for
exactly 4 minutes at room temperature. After adding 50 ng of DNA probe, the
reaction was allowed to proceed 1.5 more minutes before 25 p.l of 0.25 M EDTA was
added to stop the reaction. The resulting DNA fragments were of 100-300 base pairs
in length as confirmed by 1.2% agarose-TBE gel electrophoresis. After digestion the
DNA in the mixture was precipitated with EtOH-NH4Ac, and the pellet was
resuspended in 10 il of 50% deionized formamide, 1 X SSC, and 3 X Denhardt
solution (100 X stock solution: 2 g of BSA, 2 g of PVP, 2 g of Ficoll in 100 mL
solution). The DNA was denatured by incubation in a 70° C water bath for 10
minutes. Then it was immediately put on ice until the mixture was put onto the
prepared slide for hybridization.
The slides were brought to room temperature, prewarmed to 37° C before 10
jiL of the probe mixture was applied, then the cover slip was mounted and sealed
with 2% agarose. The slide was put into a moist chamber (moist chamber solution
has the same formamide concentration as the probe mixture) and incubated at 37° C
for overnight.
After hybridization, washing was done according to Lichteret al.(1988) with
some modifications. Briefly, the slide was washed three times, 30 minutes each in 50
mL of 50% formamide 2 X SSC at 42° C. Then it was washed three times, 30
minutes each in 50 mL of 0.05 X SSC at 42° C.
The bound digoxigenin detection was done with Fluorescent Antibody
Enhancer Set for DIG Detection kit (Boehringer Mannheim) as described in the
manufacturer's instructions. After washing, the slide was washed briefly with the
blocking solution (1:10 dilution of supplied blocking solution (vial #4) in PBS), and
each slide was put in a 50-mi conical polypropylene tube with 30 ml blocking
solution at room temperature for 30-60 minutes. Then the slide was drained on a132
paper towel, and 2 p.l of first antibody (anti-DIG monoclonal Ab against digoxigenin,
mouse IgGi) in 25 pJ blocking solution was added onto the cells. Next, a cover slip
was put on top and the slide was put inside a moist chamber at 37° C for 1 hour.
Afterward, the slide was washed three times briefly with PBS-Tween (0.02 % Tween
in 1 X PBS) wash solution at 37° C. The second antibody (anti-mouse-Ig-DIG,
F(ab')2 fragment) was applied, and again the slide was incubated in moist chamber at
37° C for 1 hour. After washingas before, the third antibody (anti-DIG-Fluorescein,
Fab fragments) was applied in the dark. The slide was incubated in the moist
chamber at 37° C, for 1 hour in the dark. All the manipulations doneon the slide
after this point were done in the dark. The slide was washed three times, five minutes
each at 37° C with the PBS-Tween washing solution. After air-drying, the slide was
washed several times briefly with PBS solution. It was then counterstained with
either propidium iodide (1 igIml) in PBS or Hoechst stain in PBS for five minutes.
An antifade solution, Prolong (Molecular Probes), was applied according to
manufacturer's instruction. A coverslip was then mounted on the slide and sealed
with clear nail polish the next day. The slide was viewed using a fluorescence
miscroscope (Zeiss Axiovert S 100 TV) with 100 X magnifications with oil
immersion and also a zoom lens (Dr. Jeff Greenwood, Environmental Health
Sciences Center, Cell Culture Facility at Oregon State University).
DETERMINATION OF REPLICATION TIMING WITH QUANTITATIVE PCR
The cells were synchronized using aphidicolin. Aphidicolin (3iM) was added
to the log-phase growing cells for 20 hours. This was followed by washing and
addition of medium without aphidicolin for 15 hours and again addition of
aphidicolin to the medium for another 20 hours (as described in Chapter 3). At each
time point the cells were trypsinized, washed with ice cold PBS and resuspended in
digestion buffer (100 mM NaCl, 10 mM Tris-HC1 (pH 8), 25 mM EDTA pH 8, 0.5%133
SDS, and 0.1 mg/mi proteinase K added fresh for each use). The digestionwas
allowed to continue overnight at 42° C. The DNAwas phenol/chloroform-extracted
and precipitated with ethanol! ammonium acetate (EtOH/NH4Ac) method. Itwas
immediately centrifuged in a fixed-angle Eppendorf microcentrifuge at 8000rpm for
4 minutes. The pellet was washed with ice-cold 70% ethanol, and resuspended in TE.
Usually the pellet was not readily resuspended into the solution, and it might needto
be incubated at 37°C for a couple of hours. After the pelletwas dissolved, the
concentration of DNA in the solution was determined, and 0.6 tg of DNAwas used
as template for the PCR reaction.
PCR was done in 1 OO-pi total reaction mixture. The same primersas the ones
used for screening the clones were used with annealing temperature also at 68° C. 5U
of Taq DNA polymerase was used per 1 00-tl reaction. Ten mL of the resulting PCR
reaction was loaded into the well of 1 % agarose-TBE gel stained with ethidium
bromide. After the tracking dye had run to the middle of the gel, the gelwas
visualized using a UV-lightbox. Pictures were taken, and the band intensitieswere
analyzed using ImageQuant Image analysis software.
DETERMINATION OF SPONTANEOUS MUTATION RATES
A Fluorescence-Activated Cell Sorter (FACS) was used to purge the cell
population from already arising mutants that would complicate the analysis of
spontaneous mutation rate per clone. Each clone was grown to approximately 200
million cells and harvested. Trypsinizationwas stopped with 100% FBS instead of
medium containing 10% FBS. The cells were washed twice with ice cold sterile PBS
and resuspended in about 3 ml of PBS.
The cells were analyzed with a high speed MoFlo (Cytomation, Inc., Fort
Collins, CO) FACS machine courtesy of Dr. Steven Giovannoni, Dept.
Microbiology, Oregon State University. The fluorescence gatingwas determined by134
running a two-way sort of pEGFP-transiently transfected HeLa cell population. The
phenotype of each sorted population was confirmed with a fluorescence microscope.
Usually the pEGFPamb-C 1 HeLa clonal populations were more than 99%
nonfluorescent; i.e., mutations to fluorescence phenotype did not accumulate in these
cells. The recovery of the cells after the sorting process was usually very low, in the
order of 10% from the original cell number harvested.
After sorting, depending on the calculated number of the sorted cells, the
cells were plated onto one or two 150-mm tissue culture plates (Fisher). A quarter of
the sorted cells could be used for flow cytometry to confirm the result of the sorting
process. At the indicated time point (days) the cells weretrypsinized, one half of the
cells population were taken for flow cytometry analysis, and the rest were plated
back onto a new plate using the old conditioned medium.
RESULTS
HELA CELL CLONES STABLYINCORPORATING gfp-amb GENE
Ten HeLa cell clones resistant to G4 18 were chosen and tested them for the
presence of gfp-arnb gene in their genome. Total HeLa cell DNAfrom each clone
was extracted and subjected to PCR followed bySouthern blotting to detect the
presence of the gfp-amb gene. Five clones, namely 5, 9, 10, 17and 19 were
confirmed to have the complete gfp-amb gene. All five clones showed only one
PCR-amplified band of the approximate size ('800 bp), confirming that one copy of
the gene was inserted in each location in the chromosome (Figure 4.1).
Electroporation was chosen as the method to deliver the DNA into HeLa
cells, since it was reported that stable transfectants achieved by electroporation of
DNA into mammalian cells usually resulted in cells having insertion of one copy of135
the gene per cell. Two or three copies of the gene inserted in the chromosome are
less common compared to the single-copy insertion. It was confirmed by PCR that
all five clones had only one copy of the gene inserted in one location of the
chromosome. Tandem insertion of the gene in one location in the chromosome
would show as a ladder when the PCR product was analyzed on a gel. However,
PCR method can only detect either single or tandem insertion of a particular DNA
sequence in a location in the chromosome. Therefore, Southern blotting analysis was
done to confirm that there was only one copy of gfp-amb gene per cell in each clone.
1 2 3 4 5 6 7 89 1011 12 13
Figure 4.1. PCR Screening of HeLa Clones. Lane 1 is PCR product of the
untransfected HeLa cell DNA; 2 and 3 show amplification from gfp-transfected
HeLa cells; 4 shows PCR product from pEGFP plasmid that served as positive
control; 5 and 6 show the I kb ladder; the next two lanes show PCR product from
another set of primers that resulted in nonspecific amplification of DNA from (7)
untransfected HeLa, and (8) transfected HeLa cells; and 9 through 13 are PCR
products of DNA isolated from clones 5, 9, 10, 17 and 19 respectively. 750 bp on the
ladders are shown by arrowheads. Ten pL of the PCR reaction each (total volume of
each reaction was 100 iL) was loaded into each lane of the 1.2% agarose-TBE gel
stained with EtBr. The gel was run at 100 V, for approximately 1 hour.+ 517
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Figure 4.2. Southern Blotting Analysis of Clones 5 and 17. Only one band
corresponding togfp-ambgene was present in the genomic DNA from each clone
(arrow). Lane '+' represents the positive control (1 ng ofpEGFPamb-C1 and 80 ig
of salmon sperm DNA), lane 5 and 17 represent clones 5 and 17 respectively.
The Southern analyses showed only one high molecular band for each clone chosen
for further analysis, I. e.: 5 and 17 (Figure 4.2). However, since about 80 .xg of DNA
per lane was needed in order to detect the presence of the gene using the Southern
blotting method, there was a possibility that the DNA was not restriction digested to
completion, and there was not enough separation between the fragments. For this
reason it is difficult to unambiguously interpret the result of the Southern blotting
experiment.
The presence of single-copy insertion per cell per clone was confirmed later
in the fluorescence in situ hybridization (FISH) experiment described in the next
section. Under the fluorescence microscope, almost all of the cells in the clones 5
and 17 appeared to have either single or double-dots instead of double or two
double-dots for before and after replication if thegfp-ambgene was inserted in two
different locations in the chromosome. Therefore, there is no evidence to suggest that
clones number 5 and 17 had more than a single insertion of the gfp-amb gene in their
chromosomes. Clones 9, 10 and 19 were not tested further since in initial137
experiments their spontaneous mutation rates were not linear or else were
abnormally high. Initial spontaneous mutation frequencies for clones 10 and 19 were
around 100 mutants/million cells, indicating that the gene might have increased the
spontaneous mutation rates of the clones, for example by disrupting the essential
gene or genes for DNA repair and replication in these clones.
DETERMINATION OF REPLICATION TIMING FOR EACH gfp-amb GENE
The gfp-amb gene was inserted randomly in HeLa cell chromosomes.
Therefore, some clones might arise from cells that have the gene inserted in a
chromosomal region that is replicated early in S-phase while other clones come from
cells that have the gene inserted in the chromosomal region that is replicated late in
S-phase.
Selig etal. (1992) have used FISH to analyze replication timing of single-
copy genes in human chromosomes. Even without cell-cycle synchronization they
showed that the in situ fluorescence hybridization pattern of an early-replicating gene
in a cell population consists of more double fluorescence dots for the gene and its
duplicate, indicating that more cells in the culture have completed replication of that
sequence the late replicating cells would consist of more single fluorescence dot per
cell indicating that the gene of interest had not replicated in most cells.
Using the method described above, the replication timing of the gfp-amb
genes in clone numbers 5 and 17 was analyzed.gfkgene cut from pEGFP-C 1 was
used to make the digoxigenin-labelled probes which were used for the hybridization.
Fluorescein-conjugated antibody cascade was used to detect digoxigenin-labelled
probe bound to chromosomal DNA on the slide (see MATERIALS AND
METHODS). The FISH pattern would be a single fluorescent dot per cell for the gfp-
amb gene that had not undergone replication and double-dots for the gene that had
undergone replication (Figure 4.3). Since in a log-phase growing cell population138
most cells are not replicating their DNA, the majority of the cells (about 60-70%)
would have the gene as a single copy and would appear to have single-dots.
Therefore, the difference between the early and late replicating gene in each clones
would be determined only by a small fraction of the total population. In a randomly
growing cell population, a snapshot of the FISH pattern from a population of cell in
which the g/ gene has been inserted in the genomic region that is replicated early in
S-phase would consist of a higher proportions of double dots compared to cells with
late-replicating gene. A snapshot of the FISH pattern from a population of cell in
which the gfk gene has been inserted in the region that is replicated late in S-phase
would consist of mostly single dots. From these data an order of where the gene has
been inserted among the clones tested can be constructed.
The result of the in situ hybridization experiment is shown in Table 4.1. From
these observations, clone number 5 most probably has the gfp-amb gene in the later
replicating chromosomal region compared to clone 17, and clone number 17 has the
gfp-amb gene replicated earlier during S-phase.
The replication timing of the inserted gfp-amb gene was also determined
using a quantitative PCR method to confirm the results of the FISH experiment. It
was observed that the amount of total DNA that was used for detection by PCR is
relative to the intensity of the resulting band of amplified DNA for a certain
concentration of template DNA (Figure 4.4). Since there was only one copy of the
gene per cell in each population at large, one can compare the resulting PCR
amplified band intensities of reactions using a constant DNA concentration isolated
for each time point from synchronized cell populations. When the same DNA
concentration is used for PCR reaction but there are two copies of the gfp-amb gene
per cell after it is replicated, the intensity of the resulting amplified DNA is
increased. By synchronizing the cell at early S-phase and extracting DNA from the
cells at each point during S-phase then performing quantitative PCR, we can derive
the replication timing of the gfp-amb gene for each clone. An increase of band139
Figure 4.3. Fluorescent In Situ Hybridization of Clones 5 and 17 Showing Single
and Double-Dots for gfp-amb Gene. The pictures on the right are larger versions of
each picture on the left showing either the single or double-dots more clearly.q[p-
amb gene was detected using digoxigenin probe tagged with fluorescein, and the










Determination of Replication Timing with FISH Method
Clone # Single-Dot Double-Dots
Counted Proportion Counted Proportion
5 247/273 0.905 26/273 0.095



















Figure 4.4. Relative Band Intensity as a Function of Total Amount of DNA used
in the PCR. From total template DNA of 0.5 to 1tg in 100 tL PCR, the relative
band intensity (measured as volume in ImageQuant analysis) increased when the
amplified DNA was run on 1% TBE-agarose gel as pictures in (A). The band
intensities were quantified using ImageQuant (B).142
intensities would represent the time in the S-phase that the gene has been replicated
(pointed by the arrows in Figure 4.5).
In practice, there are a lot of factors that can affect the results of quantitative
PCR experiments described above. For example, the intensity of each band depends
on the concentration of ethidium bromide (EtBr) in the gel. For comparison
purposes, the uniformity of EtBr concentration throughout the gel and the uniformity
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Figure 4.5. Diagram of Relative Template Concentration versus Replication
Timing. The above diagram showed how in a single copy gene the relative template
concentration varies throughout S-phase depending on when the gene is replicated.
With a constant amount of isolated DNA used, relative template concentration in a
PCR resulted in different band intensities, which can be used to deduce the
replication timing of the gene.143
Figure 4.6. Result of Quantitative PCR for Replication Timing Determination.
A. The synchronization using aphidicolin resulted in about 80% synchrony of the
cell population through S-phase. The DNA content profiles for 0, 3, 6 and 10 hours
after S-phase are shown from left to right for each clone. The resulting PCR bands
(B). also from 0, 3, 6 and 10 hours after S-phase, were quantified using ImageQuant
software (the numbers are average band intensities (analyzed as volumes using the
software and automatically corrected for local averages)) and graphed in C. Error
bars represent the average of the two bands. Open bars in C represent 0 hour after 5-
phase, striped bars 0 to 3 hours, grey bars 3 to 6 and black chequered bars 6 to 10
hours after S-phase. Arrows showed the bands representing the loading control for














































comparison between bands in each lane. Although inherent drawbacks of the assay
exist, the result together with the previous observation from the FISH experiment can
still be used to determine the replication timing of the gfp-amb gene in each clone.
From quantitative PCR measurements (Figure 4.6), clone number 5 seemed
to have a gradual increase in band intensity with the highest peak at 6-10 hours after
S-phase. The last peak (6-10 hours after onset of S-phase) did not decrease in
intensity (as expected when replication of the gene occurred earlier than 6-10 hours
after onset of S-phase); therefore, most of the replication of the gene probably did
occur at late S-phase (6-10 hours). Earlier replication (gradual increase in band
intensities earlier in S-phase) could be attributed to the somewhat lower degree of
synchrony of the culture (80% synchrony) and higher background reading. It could
also be attributed to the gfp-amb replicated close to the 6-hour border in late S-phase.
This result of the FISH experiment also showed that clone 5 was the later replicating
clone of the gfp-amb gene out of the two clones tested which corresponded with the
result of the quantitative PCR experiment (Figure 4.6).
Clone numberl 7 had the expected two-fold increase in band intensity in the
middle of S-phase (between 0-3 to 3-6 hours after onset of S-phase). The result of
FISH experiment for clone 17 indicated that the gfp-amb gene was replicated earlier
than clone 5. Taken together, these results suggested that clone 17 was a middle
replicating clone of g/v-amb gene.
gfp-amb REVERSION RATE MEASUREMENTS
One can obtain measurements of spontaneous mutation rates without the
complication of the fluctuation theory (Luria and Deibruck, 1943) if one can purge
from the cell populations the mutants that had already arisen as a result of growing
the population to high enough cell number (Bach! et al.! 999). When spontaneous
mutation is measured in paral!e! cultures without selection against mutants during146
growth, the standard deviation between the replicate cultures would be greater than
the mean, and hence the need for fluctuation theory.
Using thegfp-ambgene product which does not exhibit a green fluorescence
phenotype, one can sort and collect cells which have not reverted to the green
fluorescence phenotype by using Fluorescence Activated Cell Sorting (FACS) after
growing the cell population to high enough number to allow the detection of
spontaneous mutagenesis in one generation time. In principle, one can then detect the
linear increase in revertant frequencies of thegfp-ambgene of each clone, which
would represent the spontaneous mutation rate of the gene in each clone (Bachiet
al., 1999).
Figure 4.7 shows a population of HeLa cells that had been transiently
transfected with pEGFP-C 1. The fluorescence intensity of GFP from pEGFP-C 1 was
readily distinguishable from the nonfluorescent HeLa cell background. Before
sorting about 15% of the cells were fluorescent. Using the MoFlo high speed FACS
machine, two-way sorting which resulted in enrichment of both populations were
done. As shown, after the sort each population;i.e.,fluorescent and non-fluorescent
HeLa cells are of 99% purity. The phenotype of cells from each population can be
confirmed using a fluorescence microscope.
Using fluorescent HeLa cell populations as above, the flow cytometry
instrument gating was set to define "a fluorescent HeLa cell". Revertant frequency is
defined as the fraction of cell population that is fluorescent as defined by the
instrument gating compared to total number of cells run through the flow cytometer.
Clones number 5 and 17 were analyzed repeatedly. In every case clone 5
accumulated more mutations than clone 17 after 5 days. The mutation frequency of
clone 5 was higher than that of clone 17 in four experiments that was performed.
However, there was considerable scatter on the mutation frequency data obtained
daily for each clone. The small number of actual revertants collected in every
experiment is a factor contributing to the scatter in the data (Table 4.2). Reversion of
a single base pair in a single-copy gene is a very rare event; therefore, eventhough as147
Figure 4.7. Determination of Fluorescence Gating for HeLa Cells Expressing
GFP. PEGFP-transfected HeLa cells were used to determine the fluorescence
intensity of GFP in HeLa cells. Two-way sorting using the predetermined gating
resulted in populations of fluorescent (RI gating) and non-fluorescent HeLa cells
with more than 99% purity (enhancement of the population under Ri gating, i.e.: the
right graph of cell number versus fluorescence intensity).This gating (Ri) was used
in the flow cytometry analysis to determine whether a cell has reverted its gfp-amb
gene to give a fluorescent phenotype of GFP (the top pictures of cells each represents
a cell viewed using a light microscope and the bottom the same cell using
fluorescence microscope).148
many cells as possible were collected to run on the flow cytometry, the actual
number of revertants collected was still small especially for the first day of the
experiment. Nonetheless, the result of every paired experiment was consistent;
therefore, it was concluded that in similar experimental conditions clone 5, the late
replicating gfp-amb clone, accumulated mutants at least two fold more rapid than
clone 17, the middle replicating gfp-amb clone.
Table 4.2
Comparison of Mutants Acquired in Clones 5 and 17
days revertants accumulated
clone 5 clone 17
mutanttotal mutanttotal
1 0 320,802 1 353,337
2 5 2,715,160 10 3,000,000
3 3 573,151 0 579,916
4 8 2,927,151 13 3,600,000
5 14 2,000,000 7 2,000,000
The spontaneous mutation rates expressed in number of revertants per cell
per generation for both clones were derived from the experiment presented in Figure
4.8. The cells were doubling approximately every 36 hours, probably since they
were trypsinized and replated repeatedly during the length of the experiment. The
mutation rate for clone 5 was calculated to be about two per million cells per
generation, whereas the mutation rate for clone 17 was calculated to be less than one
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Figure 4.8. Estimation of Spontaneous Mutation Rates for Clones 5 and 17.
Clone 5, which is the late replicating clone of gfp-amb gene, has a higher
spontaneous mutation rate than clone 17, which was the middle-replicating clone.
Clone 5 is represented in black diamonds and 17 in gray triangles. For clone 17, the
revertant frequency at 3 days was not used in constructing the linear mutation rate
curve.
DISCUSSION
The use of green fluorescent protein to study spontaneous mutation rates was
put forth as an alternative to the complicated method of fluctuation analysis used to
evaluate spontaneous mutation rate (Bachl et al., 1999). These investigators used an
amber mutant of gj gene that is stably transfected inAjt(a derivative of the A-
MuLV-transformed pre-B cell line 18-81) cell line to evaluate the hypermutable rate150
of these cells. In this report the use of the green fluorescent protein was adapted to
determine whether the mutation frequency of a particular gene sequence varies
depending upon whether the gene is replicated early or late in S-phase.
A tyro sine to amber mutation in thegfgene sequence of the pEGFP-C 1 was
constructed, and HeLa cells were transfected with the linearized vector. Five clones
that have the complete gfp-arnb gene stably inserted into the chromosomes were
isolated, and the replication timing of the gfp-amb gene in two of the clones was
determined. For each clone, revertant frequencies of the gfp-amb gene which gave
rise to green fluorescent HeLa cells were analyzed, and the mutation rates of the
different clones were compared.
In adapting the technique of using g,fj as the reporter gene for spontaneous
mutation (Bachl et al., 1999) in this study, there were several limitations. First, the
expected spontaneous mutation rate in HeLa cells should be much lower than the rate
of the hypermutable At cells. Theoretically, a lot more than one million cells
analyzed through the flow cytometer at one time was needed in order to detect just a
few mutants. The sensitivity of the experiment would be higher a forward mutation,
i.e., analysing the number of non-fluorescent mutants from clones of HeLa cells
stably expressing the green fluorescence protein (GFP) was done instead. However,
it was difficult to isolate HeLa cell clones that were stably expressing the GFP. Most
of the cells that were fluorescent after transfection with pEGFP would soon look
unhealthy and rounded under the fluorescence microscope. After one month, none of
the G4 18-resistant transfected HeLa cells were fluorescent, in contrast to 2O% at 48
hours after transfection. Whether the disappearance of the fluorescent HeLa cell
population was due to cell death or slower doubling time of the fluorescent HeLa
cells compared to the non-fluorescent cells was not determined. As mentioned
before, Liu et al. (1999) have noted that expression of GFP seemed to be toxic in
their mammalian cell lines and have linked the expression of GFP in these cells with
the appearance of apoptotic markers. Their phenotypic observation of unhealthy cells151
expressing GFP correlates well with my observation of the HeLa cells expressing the
GFP.
Second, there seems to be a lag time for the fluorescence development of the
GFP that was also observed by Bachiet al.(1999). The delay in the development of
GFP fluorescence after expression in cells was noted previously (Kainet al.,1995,
Yangetal.,1996, Tsien, 1998). At the time of sorting, some genes might already
have a mutated DNA sequence but if the protein had been already expressed then it
was not yet fluorescent. Without completely purging the cell populations of the
mutant cells already present, each population would have a different number of
revertants to start the experiment, and that could make estimating the spontaneous
mutation rate inaccurate.
Some of the factors that complicated the analysis of mutation rate are
intrinsic to the GFP, as was described above. The toxicity of GFP for HeLa cells
possibly can lengthen the revertant cells' doubling time compared to the non-
revertant cells or even killing the cells, which would greatly affect the observed
number of revertants per day. Other factors are related to the experimental
conditions, such as plating efficiency, cell growth density, the length that each cell
population is subjected to sheath fluid in the sorting process,etc.Since HeLa cells
used were not the HeLa S3 cells that can be adapted to spinner culture, for every
time point the cell populations were trypsinized and a portion of the cell populations
was used for the flow cytometry experiment. The rest of the cells were platedback
with the old conditioned medium. And since the actual number of revertants was
small, differences in plating efficiency can account for the observed scatter in the
data. Another experimental condition that seems also to contribute to differences in
observable mutation rate was cell density during growth. Boesenet al.(1994) noted
a difference of 30-fold in observable mutation rate just by varying the celldensity in
cultures. To lessen the effect of experimental variations only comparison of mutation
rates of clones in which data was taken from the same set of experiments were done.152
For clone 5 and 17, repeated paired experiments suggested that there was a
linear relationship between the observed revertant frequency and time for all of the
cell populations tested. Clone 5, which was designated as a late-replicatinggfp-amb
clone, had always at least two-fold higher spontaneous mutation rate than did clone
17, which was a middle-replicatinggfp-ambclone. In the paired experiments, clones
5 and 17 were affected similarly by certain experimental factors; therefore, the
difference in the spontaneous mutation rate between the two clones should be valid.
This observation indicates the existence of temporal differences in spontaneous
mutation rates for human chromosomes. More studies would be needed to prove that
our observation is a general phenomenon rather than an exception of thegfp-amb
sequence used or the clones selected.
The implication that replication in middle S-phase is more accurate compared
to late in S-phase is concurrent with slower replication rate (Collins, 1978; Collinset
al.,1980), lower average DNA accumulation rate and deoxyribonucleotide (dNTP)
pools (Figure 4.9) in middle S-phase compared to late S-phase in HeLa cells. It is
interesting especially since in the previous work it was shown that lowering the
dNTP pooi during DNA replicationin vitrocould result in lower mutation frequency
observed (Chapter 2).
Is dNTP playing a role in controlling the S-phase DNA replication rate that in
turn affects the spontaneous mutation frequency? It was also shown previously that
dNTP pools in non-transformed fibroblast cell lines were lower than in HeLa cells
(Chapter 2). If higher dNTP pools should concur with faster DNA replication rate,
and dNTP pool levels in transformed cells are generally higher than in the non-
transformed cells, then replication rates in transformed cell lines should be higher
than in the non-transformed counterpart. This was indeed observed by Collinset al.
(1980), who have shown that the S-phase DNA replication rate in W1-38 non-
transformed cell line is slower in general compared to the 2RA cells, the transformed



















Figure 4.9. Average dNTP Pool Levels and DNA Accumulation Rates for
Middle and Late S-Phase. This figure is adapted from data collected and graphed in
Figure 3.8 in Chapter 3. A is the average dNTP pool levels and B is average DNA
accumulation rates at middle and late S-phase. Grey bars in A represent dGTP,
striped dCTP, white dATP and black bars dTTP.
increase the mutation rate in these cells? Clearly, the implication of the results
presented here merits further experimentation.154
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CHAPTER 5
DISCUSSION
Perturbation of dNTP pool concentrations in various prokaryotic as well as
eukaryotic cells has long been documented to affect the observed mutation
frequencies in these cells (reviewed in Meuth, 1989, Kunz and Kohalmi, 1991, Kunz
et al., 1994). However, in most instances the mechanistic relationships between
alteration of the cells' "normal" dNTP concentrations and the resulting effects such
as increases in substitution mutations or DNA strand breaks were not clear, and the
proposed mechanisms of mutations involving dNTPs alteration do not explain the
observable effects consistently. In the case of mammalian cells, to which the studies
presented in this thesis are focused, the nature of the cells' chromosomal DNA
replication that is not completely understood posed an added complication in
understanding the relationship between dNTPs as building blocks for DNA
replication and mammalian DNA replication fidelity.
The measured dNTP concentrations in cells during S-phase represent steady
state dNTP concentrations resulting from the balance of dNTP production less the
rate of their utilization in DNA replication and the rate of turnover reactions which
maintain tight control over accumulation of dNTP pools in cells (Reichard, 1988). It
was previously calculated that the measured dNTP concentrations in mammalian
cells were only enough to support a few minutes of chromosomal DNA replication.
This notion underscores the dynamic nature of the measured pools. From in vitro
mammalian DNA replication studies employing SV 40 origin of replication, SV 40
Large T antigen and human cell extracts, it was noted that high dNTP pool
concentrations during DNA replication increase mutation frequency and low dNTP
pool concentrations during replication result in higher DNA replication fidelity
(Kunkel, 1 992a). High dNTP concentrations during replication are thought to result157
in "next-nucleotide" effects (Kunkel, 1988), effectively "sealing-in" any mismatch in
the previous template-DNA pair due to the enhanced rate of subsequent
polymerization over a mismatch. With low dNTP concentrations during replication,
it is thought that sufficient time for proofreading of a mismatch in the previous
template-DNA pair is facilitated by slow DNA polymerization rate. However, kinetic
mechanisms of DNA polymerization indicated that incorrect incorporation involves
an additional rate-limiting step not observed for correct polymerization (reviewed in
Johnson, 1993). The kinetic constants for exonucleolytic partitioning indicate that
polymerization over a misincorporated nucleotide is extremely slow even without
pool imbalance, questioning the significance of "slower" polymerization when next-
nucleotide to be incorporated is low in concentration.
In mammalian cellsin vivo,dNTPs are produced in cytoplasm while DNA
replication occurs in the nuclei. There is strong evidence of the tight regulation of
dNTP pools in cells (reviewed in Reichard, 1988). It has been noted also that
replication fork movement in S-phase in HeLa cells increases as cells progress
through S-phase. Nonetheless, the relationship between the measured dNTP pools
and DNA replication rate in mammalian cells in S-phase has not been established.
Another consideration for mammalian chromosomal DNA replication is the
extremely large amounts of DNA that need to be replicated in short periods of time.
It would seem that replication in a mammalian cell at less than an optimum
polymerization rate is not an advantage.
In Chapter 2 of this thesis, the effect of the under-representation of dGTP in
the measured mammalian cells' dNTP pools is studied using thein vitroSV 40 DNA
replication system. Most of the studies involving observed increases in cells'
mutation frequency that correspond to "imbalances" or alterations of the ratio of the
four dNTP pools in the cells attributed the dNTP imbalance as the source of the
increase in mutation. Higher concentration of one dNTP over others is thought to
increase the possibility that the over-represented dNTP will be misincorporated more
frequently since the nature of polymerization of a template with four different158
possible substrates lends itself to substrate competition to the active site. However,
as shown in Chapter 2, in thein vitroreplication reaction, high concentration of one
dNTPrelative to otherdNTPsdid not seem to increase its misincorporation rate but
increases the mutation frequency of the mismatch immediately before incorporation
of the over-represented dNTP in DNA. Replication with biologically biased dNTP
concentrations based on the calculated HeLa nucleardNTP pools(60, 60, 30 and 10
tM for dATP, dTTP, dCTP and dGTP respectively, Leeds et al., 1985) did not affect
the observed mutation frequency when compared to replication with equimolar
dNTP (100 tiM) concentrations. It is possible that thisinvitro observation is a
consequence of the next-nucleotide effect. When dNTP concentrations are at certain
ranges, lowering one dNTP pool did not immediately affect the observed mutation
frequency since there is no considerable changes in the ability of otherdNTPsto seal
the resulting mismatches through next-nucleotide effect. To put it differently, when
dNTPlevels during replication are in the range of theKM5of mismatched extensions
or lower, small changes in thedNTPratio that may cause insertion errors are not
affecting the mutation frequency since the concentration of the next correct
nucleotide is not high enough too seal any errors made.
Very low mutation frequency is observed when replication is done with
dNTPsat calculated diploid fibroblast concentrations. AlldNTPlevels in the diploid
fibroblast concentrations were about three- to four-fold lower than biologically
biased dNTP pool calculated from HeLa cells. Both HeLa and diploid fibroblast
dNTP concentrations used in the in vitro replication reactions are significantly higher
than the reportedKdfor poi6-dNTPbinding (0.93 jtM) orKMfordNTP(0.067-1.2
p.M depending on the presence or absence of PCNA) (Einolf and Guengerich, 2000).
This should imply that in both reactions the polymerization rate should be maximal;
however, a slight decrease in polymerization rate was also observed for reactions
with diploid fibroblast concentrations. Even if some of the decrease in mutation
frequency is due to slow polymerization to facilitate proofreading, the result of the
decreased ability to seal-in most mismatches due to low concentrations of next159
correct nucleotides available in replication reaction with lower dNTP concentrations
should also play a factor. In the misincorporation kinetic study done for T7 DNA
polymerase, theKMfor the correct dNTP addition over a mismatch is only four times
higher than that of correct dNTP over correct dNTP (Wong etal., 1990).Kinetic
studies of DNA polymerase 6 to date indicated similarities of polymerization kinetics
between polymerase 6 and other prokaryotic DNA polymerases that have been
studied more extensively (Einolf and Guengerich, 2000). If the difference inKMSfor
correct additionversusincorrect addition over a mismatch observed for T7 DNA
polymerase also holds true for mammalian DNA polymerases,KMfor mismatches
that is only four-fold higher thanKMfor correct polymerization would suggest that in
the SV 40 in vitro replication reaction with biologically biased dNTP calculated for
HeLa cell nuclei or with 100 tM equimolar dNTP concentrations, significantly
higher numbers of mismatches can be sealed-in at least initially by mechanism of
next-nucleotide effect when compared to reactions with diploid fibroblast dNTP
concentrations. Of course in vivo, the sequence specific and other factors influencing
replication fidelity in different regions in mammalian genome probably modulate the
effect of dNTP levels on mutation frequency observed.
In chapters that followed, the relationship between overall level of dNTP in
cells and the observed mutation frequency was studied. This notion is distinct from
the widely observed increases in mutation frequency as the result of changes in the
ratio of the four-dNTP pools in cells. The slow rate of mutation of the middle-
replicating HeLaGFP-arnbcloneversusfaster rate of mutation of the late-replicating
clone (Chapter 4) corresponded with the modulation of the measured dNTP levels
and DNA accumulation rates during S-phase in HeLa cells (Chapter 3). HeLa cell
dNTP pooi analysis during S-phase showed that the dNTP pool in the middle of S-
phase is relatively low compared to dNTP pool levels in late S-phase. Concurrent
analysis of DNA accumulation rate during S-phase showed that lower average total
dNTP pools in middle S-phase corresponded to lower average DNA accumulation
rate, although no conclusions can be drawn when more detailed study of dNTP pool160
levels and DNA accumulation rates during S-phasewere conducted. Although the
actual replication fork growth in different time in S-phasewas not measured in the
study, several reports have shown that the rate in replication fork movement
increases in HeLa cells as the cells proceed through S-phase (Painter and Schaeffer,
1971, Housman and Huberman, 1975). Chromosomal mammalian DNA replication
has been shown to involve other DNA polymerases suchas DNA pol,and in vivo,
other factors can modulate DNA replication rate as well as dNTP pooi levels inways
that are not clear to date. To substantiate the direct effect of dNTP pool levelson
DNA replication rate, measurement of changes in the replication fork growth in
response to experimentally introduced changes in dNTP pool levels at different time
in S-phase is needed. Experiments measuring the change in replication fork
movement in response to an introduced increase in dGTP level would provide
convincing evidence that low dGTP pool levels affect DNA replication rate.
Higher dNTP concentrations in late S-phase in HeLa cells corresponds to the
observation of higher mutation rate of the late-replicating GFP-amb HeLa clone, and
lower overall dNTP concentrations in the middle of S-phase corresponds to a lower
mutation rate of the middle-replicating clone. These observations agree with the
results obtained from in vitro replication study. Although more studies need to be
done, it is tempting to speculate that the increase in mutation rate seen is the result of
the increase of dNTP pooi levels during replication and also the replication rate.
Higher dNTP pool levels and hence replication rate can relate to the higher
mutation rate observed. Kinetic studies suggest that the enhanced rate of binding of
excess nucleotide to the enzyme-DNA complex does not necessarily result in
"sealing-in" the mismatch directly 5' to it since the rate limiting step for
polymerization of the mismatched nucleotide is the formation of the phosphodiester
bond, which is extremely slow for a mispair. Moreover, it has been observed that the
proofreading exonucease activity not only can excise mismatches present in the
primer-template termini but it can also correct "buried" mismatches. An increase in
the proportion of the enzyme-mismatch DNA complex that is bound to the next161
correct nucleotide (as the result of higher dNTP levels during replication) probably
does not increase the efficiency of mismatch extension. However, the [enzyme-
mismatch DNA terminus-next correct nucleotide] complexcan exist in a
conformation that inhibits the movement of the primer-template DNA terminus into
the exonuclease site and hence decreases the proofreading efficiency in thepresence
of high dNTP concentrations. Since the next two, three and four nucleotides aftera
mismatch are also present at high concentrations, the mismatchcan effectively be
"sealed-in" when all dNTPs are present at high concentration during replication.
However, for in vivo DNA synthesis, other factors such as DNA mismatch repair,
can still correct mispairs that are not corrected by the proofreading exonuclease
during DNA replication.
It has been noted that in mammalian cells, most housekeeping and active
genes are replicated early in S-phase while the non-transcribed genes replicate late in
the S-phase. The indication that late-replicatinggenes acquires more mutations than
middle-replicating genes seems to correspond well with the temporal regulation of
genes. The average dNTP pool levels in mammalian cells also vary similarly during
S-phase. The studies presented here indicate that dNTP levels during S-phase and
hence DNA replication rate could playa factor in the modulation of DNA replication
fidelity in mammalian cells.162
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